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ABSTRACT 
One of the major limitations of the use of optoacoustics (OA) for the imaging of 
prostate cancer is the relatively low resolution when performed in real time. The work 
presented in this thesis aims to address this limitation by applying frequency-based 
analyses, which contribute additional information on sub-resolution structures to OA 
images, and may prove useful for advanced detection and monitoring of prostate cancer.   
Optoacoustic imaging was employed to distinguish physiological differences 
between tissues in in vivo mouse models (transgenic adenocarcinoma of mouse prostate 
[TRAMP] and C57Bl6) and vascular casts of mouse renal and hepatic vasculature, and 
heat-induced physiological changes in ex vivo bovine liver during laser thermal therapy 
(LTT).  Optoacoustic signal intensity and frequency spectrum analyses were performed 
on signals obtained from a reverse-mode OA imaging system (Seno Medical 
Instruments Inc., San Antonio, TX) with a 775 nm pulsed optical illumination  
Neoplastic prostate tissue and laser-induced tissue changes were identified based 
on the OA signal amplitude in combination with spectral analysis of the OA 
radiofrequency (RF) data.  Tumours generated higher amplitude signals than those of 
the surrounding tissues, with contrast ratios of 33 ± 3 dB.   In ex vivo bovine liver, the 
amplitude of the post-treatment OA signals was on average three times higher compared 
with pre-treatment signals. The RF spectrum analysis showed significant differences 
between neoplastic and normal tissues, and between pre-heated and post-heated tissues. 
The midband fit was 62% (5 dB) higher, the intercept 57% (4 dB) higher and the 
spectral slope 50% (0.4 dB/MHz) higher for neoplastic prostate tissue compared to 
normal tissues in the control mice.   
These spectral parameter values were further investigated using simple and 
complex phantoms and were found to relate to the size and density of the OA targets (in 
this case, vasculature).  During LTT, the midband fit and intercept increased on average 
by 7 ± 1 dB and 9 ± 1 dB, respectively, and the slope decreased on average by 0.3 ± 0.1 
dB.  Unlike the amplitude of the OA signal, the spectral parameters were not 
significantly affected by the temperature of the target during LTT.  The spectral 
parameters, thus, may have been affected primarily by tissue state (i.e. native or 
coagulated). Thus, this may provide a means of monitoring LTT directly using OA 
imaging, rather than through monitoring temperature which is often used as a surrogate 
of damage. 
The results of this study demonstrate that OA imaging provides high-contrast 
imaging of a murine model of prostate cancer in vivo, and real-time monitoring of LTT 
ex vivo.  Analysis of OA frequency parameters may offer information on sub-resolution 
vascular structures in the neoplastic tissue.  Optoacoustic frequency analysis may also 
offer a more direct measure of tissue thermal damage compared to temperature-based 
methods.  Such OA frequency analysis, in combination with OA thermometry, may 
represent an improved strategy for monitoring LTT.   This analysis technique may be 
applied to any OA signal to provide additional information on sub-resolution tissue 
structures.  Overall, this represents a promising technique for improving prostate tumour 
detection and real-time treatment monitoring. 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
“Learn from yesterday, live for today, hope for tomorrow. The important thing is to not 
stop questioning.” 
 
-Albert Einstein (1879-1955) 
picture from http://www.goodreads.com/author/show/9810.Albert_Einstein 
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1.1  Prostate cancer 
 Prostate cancer is the most common cancer among men in developed countries.  
An estimated 240,000 men in the United States were diagnosed with prostate cancer in 
2012, resulting in over 28,170 deaths 
1 
.    While prostate cancer can be deadly, 
approximately 95% of men diagnosed with the disease will survive over 5 years 
2
, and 
83% of men will survive more than 10 years post diagnosis if the disease is found in its 
early stages 
3
.  However, diagnosis of this disease in its early stages remains unreliable, 
and treatments of early-stage prostate cancer are often associated with adverse side 
effects 
4
.   
 1.2  Diagnosis and treatment techniques 
 Conventional diagnosis of prostate cancer involves using imaging techniques 
such as ultrasound, CT, and MRI to identify suspect areas in the prostate which are then 
biopsied for definitive diagnosis 
5
.  These imaging techniques, however, cannot reliably 
distinguish neoplastic from healthy prostate tissue with an estimated sensitivity of only 
50% 
6
.  This leads to a large sampling error associated with biopsies 
5
.  Hence, the 
ability to accurately image potentially neoplastic regions in the prostate may better 
determine if and where a biopsy is necessary (i.e. targeting).   
 One of the most common techniques used for local grading of the prostate is 
transrectal ultrasound because it can be performed in real-time and has relatively good 
resolution 
7
.  However, the accuracy of this technique is reported to be less than 50-60% 
with respect to detection of prostate cancer, due largely to the weak contrast at depth in 
soft tissues 
7–9
.  Conventional diagnosis is currently based solely on detection of gross 
3 
 
anatomic properties of tissues 
10
.  Recent ultrasound techniques have been developed 
that probe tissue microstructure based on the spectral analysis of the ultrasound 
radiofrequency (RF) data 
11,12
.  However these techniques do not provide any 
information on the oxygen saturation or hemoglobin concentration of the tissue, both of 
which are often altered with neoplasia 
13,14
.  Pure optical imaging techniques, such as 
diffuse optical tomography (DOT), are being investigated as possible targeting 
technologies for prostate cancer because of their ability to achieve adequate contrast in 
soft tissues and their ability to measure the oxygen saturation and hemoglobin 
concentrations of the tissues 
14
. These techniques, however, suffer from strong light 
scattering in biological tissues 
17
, resulting in either very limited imaging depth (<1 mm) 
as in optical coherence tomography (OCT), or limited resolution, as in DOT 
17–19
. 
 Once prostate cancer has been diagnosed, treatment can ensue.  Unfortunately, 
due to the location of the prostate and morbidity associated with current treatment 
methods (e.g. radiation, surgery), many men face difficulties with health-related quality 
of life during and post-treatment 
20
.   The most common problems involve urinary, 
sexual, and bowel dysfunctions 
3
.   These issues usually do not arise until advanced 
stages of the disease or until treatment begins 
21
. 
 The greatest downfall of current treatments of prostate cancer are that they target 
the whole prostate regardless of the size of the tumour.  This approach not only damages 
the cancerous tissue but may also damage the surrounding healthy tissue of the prostate 
which leads to the health issues previously mentioned 
5
.   New treatment methods have 
been developed that may focally target the neoplastic tissue within the prostate leaving 
the healthy prostate tissue unaffected 
8,22
.  The challenge with these treatments is that 
4 
 
they require real-time, high resolution, high contrast monitoring which cannot 
simultaneously be achieved with any current imaging modalities (e.g. CT, MRI, 
ultrasound, etc) 
8,23
.  
1.3  Optoacoustic wave generation 
1.3.1 Physics of optoacoustics 
 Optoacoustic (OA) imaging (analogous to photoacoustic imaging) overcomes 
the limitations described by merging the contrast capability of optical imaging with the 
resolution of ultrasound imaging 
16
.  Image contrast in OA imaging is related to the 
optical properties of the target, as in pure optical imaging and the thermomechanical 
properties of the target.  The resolution and the maximum imaging depth are scalable 
with the ultrasonic frequency as in ultrasound imaging 
13
.  Consequently, OA imaging 
can provide high contrast images with good resolution and penetration depth in soft 
tissue 
24,25
, potentially providing a useful monitoring technique for prostate cancer 
treatments.  This emerging technique exposes tissues to nanosecond pulsed laser light, 
which induces tissue-generated acoustic waves that are detected using wide band 
transducers 
26,27
.   
Short laser pulses are absorbed by tissue based on local optical properties and, if 
the conditions of stress confinement and thermal confinement are met, a high frequency 
pressure wave is generated 
28
.  Thermal confinement is satisfied if the duration of the 
laser pulse (τp) is less than the thermal relaxation time (τth).  The thermal relaxation time 
after absorbing a laser pulse of length τp is estimated to be 
28
;  
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                    [1] 
where DT is the thermal diffusivity of the sample and Lp is the characteristic linear 
dimension of the tissue volume being heated 
28
.  Stress confinement is satisfied when the 
duration of the laser pulse (τp) is less than the time it takes for the stress to transit the 
heated region (τs).  This value can be estimated as;  
        
  
 
                [2]  
where Lp is the characteristic linear dimension of the tissue volume being heated and c is 
the speed of sound in the tissue 
28
.   A typical value for many soft tissues is DT=1.4x10
-3
 
cm
2
/s.  So, for example, to image (i.e. resolve) a target of size 100 µm, thermal 
confinement is satisfied when the duration of the laser pulse is less than 18 µs.  To 
image (i.e. resolve) a target of size 100 µm, stress confinement, using speed of sound in 
water of 1500 m/s, is satisfied when the duration of the laser pulse is less than 60 ns.  
Under the stress confinement condition, high thermoelastic pressure can build up 
quickly creating the pressure wave which is detected as an OA signal. The propagation 
time of the pressure wave provides quantitative depth information. 
 The pressure, p(r,t) at position r and time t, which arises in response to a heat 
source H(r,t) in an acoustically homogeneous medium is governed by the following 
wave equation 
29,30
; 
           
 
  
  
   
        
 
  
 
  
                                       [3]                 
where H(r,t) is a heating function deﬁned as the thermal energy deposited per time per 
volume,    is the isobaric volume expansion coefﬁcient in K−1, and cp is the speciﬁc heat 
in J/(K*kg) 
6 
 
A solution to the wave equation describes the intensity of the generated OA 
signal which is dependent on the optical and physical properties of the target as well as 
the laser energy used;  
    Δp = μaΓΦ           [4] 
where μa is the absorption coefficient of the target, Γ is the Grüneisen parameter (i.e. 
(        where    is the speed of sound and    specific heat) which is dependent on 
several physical characteristics of the target, and Φ is the laser fluence (i.e. energy per 
unit area) 
28
.  
1.3.2 Optical absorption 
The amplitude of an OA signal is largely dependent upon the optical absorption 
properties of the target (e.g. the absorption coefficient).  The absorption coefficient 
describes the amount of light absorbed by the target, and is wavelength dependent.    
Absorption coefficient values as a function of wavelength of several biological 
chromophores are presented in Figure 1.1.   
 The large variation in absorption coefficient values with wavelength, allows for 
multi-wavelength optoacoustic imaging to be used for characterization of certain tissue 
properties 
10
.  For example, oxygenated hemoglobin (HbO2) and non-oxygenated 
hemoglobin (Hb) have different wavelength-dependent optical absorption properties.  
This allows optoacoustic imaging to differentiate between arteries (oxygenated) and  
 
 
 
7 
 
 
 
 
 
 
Figure 1.1: Absorption coefficients of deoxygenated hemoglobin (solid line), 
oxygenated hemoglobin (dashed line), lipid (dashed-dotted line), bile (circle-marked 
line) and water (dotted line) from 400 to 1600 nm . The absorption coefficient axis is in 
a logarithmic scale (adapted with permission) 
31
. 
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veins (deoxygenated) based on their relevant signal amplitudes at two wavelengths (one 
at which HbO2 has a higher absorption than Hb, and another at which Hb has a higher 
absorption than HbO2).  Furthermore, Hb and HbO2 have the same absorption at 
approximately 800 nm.  Optoacoustic signals acquired at this and other wavelengths can 
be used to calculate relative hemoglobin oxygen saturation and total hemoglobin 
concentration 
32
.  
The wavelength range between approximately 650 nm and 1100 nm is known as 
the optical window in biological tissues 
31
.  At these wavelengths light has a maximum 
penetration depth in biological tissues.    Within the optical window, scattering is the 
dominant light-tissue interaction; thus, propagating light gets diffused to a greater extent  
than at wavelengths outside the optical window 
33
.  Since scattering increases the 
distance that photons can travel,  the photons may penetrate further into the tissue 
31,34
.
   
1.3.3 Acoustic wave propagation 
  Acoustic (or sound) waves propagate in longitudinal motion (compression and 
expansion) 
35
.  They are inherently three-dimensional  and are time-dependent (t).  
Acoustic pressure,           , is often used to describe an acoustic wave.  For 
longitudinal waves, the acoustic pressure is related to the underlying particle velocity 
36
; 
                                                                            [5]  
where   is the density of the medium (kg/m-3), and c is the speed of sound in the 
medium (m/s) 
37
.   
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Acoustic waves are partially reflected and refracted by boundaries between two 
media with different densities.  The transmitted portion of the wave is 'bent' (i.e. 
refracted) 
37
.  This propagation follows Snell's Law (Figure 1.2); 
   
     
  
 
     
  
 
     
  
     [6] 
where   ,    and     are the angles of the incident, reflected and transmitted wave with 
respect to the vertical axis and c1 and c2 are the speed of sound in both media 
37
.   
Attenuation is the term used to account for loss of wave amplitude (or strength) 
due to all mechanisms, including absorption and scattering.  Amplitude decay can be 
modeled as 
36
; 
           
                                                                 [7]  
where a is the amplitude attenuation factor (dB/MHz
-1
cm
-1
) which is dependent on 
frequency, Ao is the incident amplitude of the wave and z is distance.   
1.4  Optoacoustic detection and imaging 
1.4.1 Ultrasound transducers 
Ultrasound refers to waves with frequencies that are greater than 20 kHz  
36
.  
Ultrasound transducers produce ultrasound waves that are directed into tissue and are 
reflected/transmitted at boundaries between tissues with different densities 
38
.  The 
reflected portion propagates and is then detected by the transducer. 
Almost all medical ultrasound transducers are made of lead zirconate titanate 
(PZT) 
39
.  PZT is a ceramic ferroelectric crystal, also known as a piezoelectric crystal,  
10 
 
 
 
 
                                      
Figure 1.2: Bending of acoustic waves from one medium to another with different 
density follows Snell's Law [6]. 
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that exhibits a strong piezoelectric effect 
40
.  The "piezoelectric effect" is the production 
of electricity or electric polarity in response to mechanical stress on certain crystals 
40
.  
The converse effect (reverse piezoelectric effect), is also valid, in which mechanical 
stress (compression and expansion of the crystal) can be produced by an applied 
potential difference 
39
.  Ultrasound is a mechanical wave and, therefore, by applying a 
potential difference to the piezoelectric crystal in the transducer, ultrasound waves can 
be generated by the rapid compression/expansion of the crystal.  The reflected 
ultrasound waves will also interact with the crystal by applying 'stress' which will 
generate electrical signals 
39
.   
Ultrasound transducers, or arrays of transducers (transducers connected in series) 
come in many sizes and shapes (e.g. circular, rectangular), the simplest of which 
contains one piezoelectric crystal 
41
.  The essential components of a single crystal 
transducer are shown in Figure 1.3.   
 The crystal is the most important component of the transducer and is a thin piece 
of piezoelectric material near the front surface of the transducer  
41
.  The thickness of the 
crystal dictates the frequency of vibrations that the crystal/transducer are capable of 
producing and detecting  
41
.   The front and back surfaces of the crystal are coated with 
films of electrically conducting material to facilitate connections with the electrodes 
which establish the potential difference needed to compress/expand the crystal, thereby 
generated ultrasound waves 
40
.  These electrodes also detect the signal generated in the 
crystal when the reflected waves return.  The backing material situated behind the 
crystal is heavily absorbing of ultrasound waves 
41
.  The purpose of this backing is to  
12 
 
 
 
 
 
               
                             
Figure 1.3:  The essential components of a single piezoelectric crystal transducer. 
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absorb ultrasonic energy transmitted back into the transducer and thereby dampen the 
oscillations of the crystal following a pulse.   The acoustic insulator prevents ultrasound 
waves originating from the crystal from being transmitted into the transducer housing.  
It also insulates the crystal from external sources of ultrasound 
40
.  The transducer house 
consists of a robust material that houses all the components of the transducer. 
1.4.2 Signal processing 
In OA imaging, absorber-generated pressure waves are detected by an ultrasound 
transducer (or an array of transducers).  These time-dependent signals are recorded by 
each transducer and a reconstruction (i.e. beamforming) is applied based on the type of 
transducer and array employed 
42,43
.   Beamforming is a signal processing technique that 
involves merging signals detected by numerous transducers in such a way that signals at 
certain angles experience constructive interference while signals at other angles 
experience destructive interference 
44
.  An annular array transducer (as used in this 
study) consists of several concentric piezoelectric ring sensors (Figure 1.4a).  Each of 
these rings can be described by their radius (ri) and width (wi).  An acoustic wave 
generated at a distance d from the transducer surface at time t=0 arrives at the i
th
 
transducer at time ti (Figure 1.4b).  The delay-time that a wave will reach each 
transducer can be calculated by using its radius, ri, and the speed of sound, c.  
Conversely, the distance of a target from the transducer can be calculated using the 
arrival time of the wave 
44
.   
The achievable resolution of each transducer in the array is dependent upon the 
depth, z, of the optoacoustic source, as well as on the diameter and width of the  
14 
 
 
 
 
 
Figure 1.4:  Schematics of (a) an annular array transducer consisting of 8 concentric 
piezoelectric ring sensors.  Each transducer ring has the same surface area, and (b) 
acoustic wave delay time generated by an optoacoustic source at a distance d from the 
transducer surface at time t=0 and arriving at the i
th
 transducer at time ti.   Delay times as 
a function of ti are applied to the wave detected by each transducer, thereby interpolating 
them to a common axis to be summed for optimal focusing. 
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transducer 
44
.   
A signal originating from a source at t=0 will take longer to reach transducer 
rings further from the center ring simply due to the distance that they must travel to 
reach them.  This delay is the difference between t1 and ti, and is accounted for prior to 
summing the detected signals.  Signals detected by each transducer are, thus, 
interpolated to a common axis and summed to achieve optimal focusing 
36
.  This type of 
focusing can enhance the amplitude of the signals on the axis by a factor related to the 
number of transducer rings and suppresses artifacts originating in areas away from the 
axis 
44
. 
Once this has been applied to the signal received by each ring, the resulting signal is 
referred to as an amplitude line (A-line) signal.  An image is formed by acquiring A-line 
signals across the axis parallel to the transducer and arranging them in order to produce 
a two- or three-dimensional image 
45
. 
1.4.3 Image formation  
The Hilbert transform is an important tool for signal processing and is often 
applied to OA signals 
28
.  The Hilbert transform selectively enhances 'edges' in an 
image. The Hilbert transform causes a phase shift in the bipolar pressure signals, 
producing a maximum at the transition point from positive to negative pressure.  Since 
this intercept corresponds to the approximate center of the source, Hilbert transformed 
signals are thought to be better suited for image analysis compared with the raw signals 
28
.  The Hilbert transform is described by the following equation; 
16 
 
                                                                 
  
                                [8]                                              
In this equation, Si is the raw signal received by the i
th
 ring, ri is the radius of the i
th
 ring, 
c is the speed of sound, and HT represents the Hilbert transform 
44
.   
 1.5 Optoacoustic applications 
 1.5.1 Tumour imaging 
 Solid tumours often have an increased blood flow and, therefore, have a higher 
hemoglobin concentration compared to healthy prostate tissue 
46,47
.  OA imaging takes 
advantage of the high optical absorption of hemoglobin compared with other tissue 
components, at wavelengths in the visible and near infrared (NIR) range, to generate 
higher amplitude signals in regions with higher hemoglobin concentrations (e.g. at the 
location of the tumour) 
48
.    
OA imaging has the ability to image vascular structures in vivo with high 
resolution and high contrast.  OA images of tumour vasculature have been shown by a 
number of groups 
25,48–51
.    Lao et al. (2008) monitored tumour growth of subcutaneous 
inoculated breast cancer tumour cells in a mouse over a 20 day period using a 532nm 
laser (Figure 1.5) 
49
.  They found that morphological vascular features of early tumour 
growth could be detected using OA imaging.   In addition, changes in the morphology 
and optical absorption (which is highly correlated with the total hemoglobin 
concentration of the blood at this wavelength) of the vessels were observed over the 
duration of the experiment.  Total acquisition time for each image was approximately 18 
minutes.  Laufer et al.(2012) imaged human colorectal tumour xenografts implanted  
17 
 
 
 
 
Figure 1.5: a) Schematic diagram of the optoacoustic imaging system used by Lao et al. 
(2008), and b) photograph of tumour nodule (left) and corresponding  optoacoustic 
image (right)
 32.  Reprinted with permission, Physics in Medicine and Biology, Volume 
53, Issue 15, Pages 4205 and 4207 , Figures 1 and 3 (2008). 
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subcutaneously in mice (Figure 1.6) 
52
.  Images to depths of up to 10 mm with 100 
micron spatial resolution were acquired in a longitudinal manner.  This allowed for 
tumour-related vascular features, such as vessel tortuosity, feeding vessel recruitment, 
and necrosis to be visualized over time.   Acquisition time of each image was 
approximately 8 minutes. 
Unfortunately, these images took several minutes to acquire, thus, they would 
serve as proficient tools for prostate cancer diagnosis, but would not be suitable for 
treatment monitoring.  The majority of the OA systems recently described in literature, 
with the ability to image in real time and with the highest resolution and deep 
penetration used spherical or cylindrical detection geometries 
53,54
.  For example, Brecht 
et. al acquired three-dimensional images of a nude mouse using a whole body, small 
animal scanner with spherical detection geometry 
53
.  Both kidneys are visualized, along 
with the spleen and a partial lobe of the liver with spatial resolution of approximately 
0.5 mm (Figure 1.7).  Kruger et. al. has described a hemispherical detection geometry 
system for breast cancer detection.  Blood vessels were visualized at depths up to 40 mm 
with spatial resolution of approximately 0.25 mm (Figure 1.8) 
54
.    
These detection geometries are ideal for accurate OA image reconstruction, and 
provide high contrast and resolution in real time.  However, these geometries are 
constrained by the need for access to all sides of the target.  They are not suitable for 
imaging superficial structures, such as the skin, or if strongly echogenic structures such 
as bone or lung are situated along the acoustic propagation path 
55
.  These circumstances  
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Figure 1.6: a) Schematic of the optoacoustic imaging system used by Laufer et al. 
(2012) and (right) a photograph of the imaging system showing the system in operation 
and the anaesthetized animal.  b) Optoacoustic images (maximum intensity projections) 
showing the development of human colorectal tumour LS174T and the surrounding 
vasculature between day 7 and day 12 post-inoculation.  The dashed lines indicate the 
tumour margins.  The arrows show common vascular features in the images 
52
.  
Reprinted with permission, Journal of Biomedical Optics, Volume 17, Issue 5, Figures 1 
and 4 (2012). 
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Figure 1.7:  Optoacoustic whole body scanner with spherical detection geometry.  (a) 
Experimental set up showing 64 element arc array.  (b) Three-dimensional image of a 
nude mouse acquired using 755 nm illumination 
53
.  Reprinted with permission, Journal 
of Biomedical Optics, Volume 14, Issue 6, Figures 1 and 6 (2009). 
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Figure 1.8: Optoacoustic breast imaging system with hemispherical detection geometry.  
(a) Schematic of the system. (b) Maximum intensity projection of the left breast of a 
patient (lateral projection) over a 64 x 50 mm
2
 field of view.  Hollow box represents 1 x 
1 mm
2
.  (c) Orthogonal projection with a field of view of 64 x 64 mm
2
.  Images were 
acquired using 800 nm illumination 
54
.  Reprinted with permission, Medical Physics, 
Volume 37, Issue 11, Pages 6098 and 6099 , Figures 2 and 5 (2010). 
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call for the more versatile planar detection geometry in which detection is performed 
over a finite plane using a one or two-dimensional ultrasound array  
55
.  The OA 
imaging systems that employ this geometry often resemble conventional ultrasound 
imaging systems.  Often OA imaging instruments may use existing clinical ultrasound 
scanners, sufficiently modified, so that the RF (radio frequency) acquisition can be 
triggered by the excitation laser in order to detect OA waves as well as ultrasound 
echoes 
47,56–59
.  Co-registration of the OA and ultrasound images are then relatively 
straightforward.  Then absorption-based contrast of the OA image in combination with 
the morphology based on elasto-mechanical properties in the ultrasound image can 
provide structural and functional information about the vasculature  
55,60
.   
Although, this type of OA imaging is the most versatile, particularly for clinical 
use, image quality provided by planar geometry detection rarely matches that of 
spherical or cylindrical, due to the limited detection aperture 
55
.  This often limits lateral 
resolution 
55
.  Axial resolution is relatively independent of the detection aperture and is 
limited largely by acoustic attenuation.  This discrepancy between the two spatial 
resolutions leads to an anisotropic spatial point spread function, which introduces 
artifacts into the images during reconstruction 
55
.   
Real-time optoacoustic imaging has been demonstrated using planar geometry 
detection to visualize tumours in vivo 
61
.  An example of this is provided in Figure 1.9 
showing superimposed ultrasound and optoacoustic B-mode images of a pancreatic 
tumour in a mouse with spatial resolution greater than 1 mm 
61
.  As is evident in Figure 
1.9, the resolution of these images rarely matches the resolution of images acquired  
23 
 
 
 
 
 
 
                    
Figure 1.9: Optoacoustic imaging system using conventional ultrasound linear array 
detection.  (a) Cross-sectional view of the optoacoustic imaging system set up using a 
clinical ultrasound probe providing simultaneous optoacoustic and ultrasound imaging.  
(b) Ultrasound and optoacoustic images (800 nm illumination) of a tumour (Panc-1 
pancreatic cancer cells six weeks after implantation into a mouse) and surrounding 
regions.  Sagittal (x-z) plane (top), optoacoustic image (middle) and superimposed 
images (bottom).  Scale bar denotes 2 mm 
61
. Reprinted with permission, Physics in 
Medicine and Biology, Volume 58, Issue 1, Pages N4 and N10 , Figures 2 and 9 (2013). 
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using a spherical or cylindrical detection system.  Three-dimensional, OA images with 
spatial resolution of approximately 100 µm were acquired using planar detection 
systems as shown by Laufer et. al. in Figure 1.10 
51
.  However, these images necessitate 
axial and lateral mechanical scanning which consequently increases imaging time (the 
OA images in Figure 1.10b was acquired in approximately 15 minutes) 
51
.  Thus 
imaging time remains a common limiting factor for three-dimensional planar detection 
systems for clinical use 
50,62
. 
Thus, planar detection geometry, although ideal for clinical use, lacks the 
necessary resolution or cannot be performed in real time 
55
.  In order to overcome these 
limitations, the mechanical scanning speed must be increased (limited, and often itself 
introduces artifacts) or the resolution of two-dimensional OA images must be improved.   
1.5.2  Temperature monitoring 
The amplitude of an OA signal is dependent upon the Grüneisen parameter, 
which increases with temperature, and therefore has been used to monitor temperature 
changes during LTT 
63
.  The amplitude is also dependent on the optical absorption 
properties of the target tissues which provides the opportunity to take advantage of the  
significant changes in tissue optical properties, at wavelengths in the visible and near 
infrared (NIR) range, due to thermal coagulation 
63
.   Larin et al (2005), demonstrate that 
during heating of an ex vivo canine liver, OA signal amplitude increased at a constant 
rate to approximately 53°C at which point the amplitude began to increase at an 
accelerated rate (Figure 1.11).  It was hypothesized that this change in slope occurs at 
the point of  
25 
 
 
 
 
 
 
Figure 1.10:  Optoacoustic small animal brain imaging system with planar detection 
geometry . (a) Experimental set up.  Excitation laser pulses emitted by a tunable OPO 
laser system.  A second laser emitting at 1550 nm provides a focused interrogation laser 
beam that is raster scanned over the surface. (b) Optoacoustic images of mouse brain 
vasculature obtained using 590 nm excitation laser. Left schematic of superficial 
cerebral vascular anatomy: A, superior sagittal sinus; B, transverse sinus; C, inferior 
cerebral vein.  Top optoacoustic image, x-y maximum intensity projection (MIP), 
bottom optoacoustic image, y-z MIP.  Total imaging time: 15 minutes 
51
.  Reprinted 
with permission, Applied Optics, Volume 48, Issue 10, Pages D301 and D303 , Figures 
1 and 2 (2009). 
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Figure 1.11:  Schematic (a) of the optoacoustic imaging system employed by Larin et 
al. (2005)  (b)Amplitude of OA pressure induced in canine liver during conductive 
heating and passive cooling.  The triangles represent heating without coagulation, circles 
represent heating with coagulation and squares represent cooling of sample 
64
.  
Reprinted with permission, Journal of Physics - London, Volume 38, Issue 15, Pages 
2647 and 2648 , Figures 1 and 3 (2005). 
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coagulation 
64
.  Shah et al. (2008)  created thermal maps in ex vivo animal tissue and 
tissue-mimicking phantoms using optoacoustic imaging by monitoring the changes in 
the OA signal during photothermal therapy (Figure 1.12c) 
47
.   They found that the OA 
signal increased as the temperature increased from an initial temperature of 25°C, to 35 
°C.   This data was compared with ultrasound data acquired simultaneouly and showed 
that OA contrast to noise ratio (CNR) was 45 ± 5 dB while that of ultrasound was 24 ± 4 
dB an almost two-fold increase (Figure 1.12b) 
47
.  
Significant changes in tissue physical properties also arise during coagulation, 
such as blood vessels constriction, increased optical scattering, and protein unfolding 
65
.   
These changes may influence the frequency content of the OA signals and frequency 
analysis of these signals may provide additional information about the tissue state (see 
section 1.6). 
1.6  Frequency spectrum analysis 
 In addition to the amplitude, the frequency content of the OA signals may 
provide sub-resolution information, making relatively low-resolution OA images more 
viable for clinical use 
66
.  This is especially important for system that are confined to 
planar detection as their resolution is often low (> 0.5 mm) when operating in real time   
56
.   Even if vascular structures themselves are not resolved in the reconstructed images 
(reconstruction often loses a great deal of information, particularly the sub-resolution  
detail 
67
), the frequency content of the generated OA signals may be used to identify 
tissue regions with specific vascular characteristics which may indicate the presence of 
disease (or other specific tissues).   Phantom and simulation studies by Yang  
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Figure 1.12: Schematic (a) of the optoacoustic set-up used by Shah et al. (2008)  (b) 
Contrast to noise ratios (CNR) of ultrasound and optoacoustic signals during heating 
indicating that the CNR of both methods increase with temperature and that 
optoacoustic has a greater CNR than ultrasound in this temperature range.  (c) 
Successive optoacoustic signals plotted for increasing temperature demonstrating that 
the amplitude increases with temperature 
47
.  Reprinted with permission, Journal of 
Biomedical Optics, Volume 13, Issue 3, Figures 1 and 4 (2008).     
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et al (2012), and Xu et al.(2004) have experimentally confirmed the feasibility of 
discriminating sub-resolution target size and concentrations based on the OA frequency 
spectrum characteristics 
68,69
.   This may provide essential information about the target 
that replaces the need for very high resolution imaging, which is associated with long 
acquisition times when using planar detection geometry 
55
.  
1.6.1  Ultrasound frequency spectrum analysis 
The information content of a transducer‟s signal is related to the frequency 
response and the field profile of the transducer 
70
.  As the number of transducer locations 
decreases, limiting the system‟s resolution, the information content from each individual 
signal remains unchanged.  There is significant information with sub-resolution detail 
contained in each OA signal 
71,72
.    For example, it is known that the size and 
concentration of the optical absorber dictates the frequency content of the OA RF 
signals 
73,74
.  Work is ongoing to identify how other target characteristics are manifested 
in the frequency content of the OA signals as well 
68,69
. 
Spectrum analysis of ultrasound RF data and its relation to tissue microstructure 
has been well described 
75
.  During the 1970‟s, means of computing quantitative, 
calibrated, averaged power spectrum from a region of interest (ROI) were developed, 
which remove system-specific artifacts, and thus provide quantitative analysis 
76
.  
Analysis of the frequency components of the RF signals has been shown to significantly 
improve the diagnostic capabilities of conventional ultrasound imaging 
11,76
.    
The size of the scattering structures compared to the wavelength of the incident 
ultrasound modifies the frequency content of the backscattered signal 
77
. Therefore, the 
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frequency analysis of the ultrasound backscatter RF signals may hold useful information 
about the sub-resolution structures in tissues.  Large databases have been developed, 
which are used with statistical classifiers to identify specific tissue types from spectral 
image data 
11
.  Analysis of the frequency components of the RF signals improves the 
diagnostic capabilities of conventional ultrasound imaging 
11,75,78
.   
 A power spectrum of the RF signals as well as the transducer-specific power 
spectrum are calculated.  The transducer's power spectrum is subtracted from the RF 
power spectrum to remove any system-dependent features from the analysis 
76
.  A 
representative calibrated power spectrum is shown in Figure 1.13 with a linear fit 
applied between 1 and 6 MHz.  The spectral components of the calibrated power spectra 
(e.g. slope, intercept and midband fit of the linear best fit to the spectral data) are related 
to the physical characteristics of the target scatterer and are visually depicted in Figure 
1.13.  Assuming the Born approximation (random scatterer distribution and weak 
scattering) represents soft tissue scattering, the spectral slope will increase and the 
spectral intercept will decrease with decreasing size of the scatterer and the midband fit 
is dependent on the size, shape and acoustic impedance of the scatterer 
11
.   Differences 
in spectral components of neoplastic tissue compared with healthy tissue have already 
been demonstrated for ultrasound RF data 
11
.  Neoplastic tissues have different 
microstructure than that of healthy tissue, for example, neoplastic tissues are often 
denser than normal tissue and consist of more turbulent vasculature 
79
.  This leads to 
significant differences in the spectral components associated with neoplastic tissue  
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Figure 1.13 A representative calibrated power spectrum with linear fit applied between 
1 and 6 MHz.  Visual depictions of the midband fit, intercept and slope are presented. 
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compared to many healthy tissues 
80
.  Significant changes to ultrasonic spectral 
components have also been observed during treatment of neoplastic tissue 
81
. 
 1.6.2  Optoacoustic frequency spectrum analysis 
The frequency content of the generated OA RF signals is broadband and the 
detected signals are limited by the finite bandwidth of the ultrasound transducers and the 
frequency dependent attenuation of ultrasound in tissue 
73
.   Since RF data are collected 
in OA imaging, and the size of the absorbing structure contributes to the frequency 
content of the OA signal 
13,73
, the relationship between the spectral parameters of OA 
data may also be linked to the physical properties of the target.  The midband fit and 
intercept are directly affected by the amplitude of the signal.  Therefore, they will 
increase as the size and concentration of the absorber increases, since the volume and 
concentration of the OA targets determine the total optical absorbance and, 
consequently, the magnitude of the OA signal.   Midband fit may be superior to 
amplitude based on the relative increases of each parameter with change in size and 
concentration of the target.  The slope of the OA frequency spectrum will decrease as 
the target diameter increases because a target with a larger diameter will theoretically 
generate a signal with a lower frequency, and this will result in a shift in the signal 
center frequency towards low frequency 
74
.   The slope value should not be affected by 
changes to the target concentration and, thus, should be affected minimally by OA 
signal amplitude 
69
. 
Using the slope and the midband fit together, size and concentration of OA 
targets can be inferred.  If the OA slope generated from target 'A' is greater than the 
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slope generated from target 'B' then we can deduce that target 'A' is smaller in size than 
target 'B'.  Therefore, the midband fit generated by target 'A' would be less than that 
generated by target 'B' at similar concentrations.  If the midband fit generated by target 
'A' is less than that of target 'B' then the concentration of target 'A' is less than or similar 
to that of target 'B'.  If the midband fit generated from 'A' is greater than that generated 
from target 'B' then the concentration of 'A' is greater than that of 'B'. 
Spectrum analysis of OA RF signals generated by blood vessel phantoms 
(cylindrical tubes filled with ink and embedded into gelatin) show a relationship 
between the  spectral components and the diameter of the cylinders 
74
.  Spectrum 
analysis of high-frequency OA imaging of ex vivo ocular tissue has also shown changes 
in the midband fit and slope around the pigmented iris 
82
.  Thus, the relationship 
between the frequency spectrum of OA data is likely linked to the physical properties of 
the target and, more specifically, the spatial distribution and size of the absorbing targets 
within the tissues 
82
.  
 1.7  Murine models of prostate cancer 
 Prostate cancer rarely arises spontaneously in animals 
83
.  Existing prostate 
cancer models include rodent models, human cell lines, and gene transfer and transgenic 
models 
83
.  Only transgenic models provide the spectrum of disease as it occurs in men, 
including progression from prostate intraepithelial neoplasia (PIN) through androgen-
dependence to androgen-independence and metastases 
83
.   
 Seventeen human prostate cancer cell lines have been described by Bokhoven et 
al. (2003)  
84
.  An issue with cell lines is that they are often derived from metastatic 
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lesions, therefore they do not allow for genetic alterations that change normal prostate 
cells into malignant cells to be investigated 
84
.   
Prostate cancer occurs naturally in dogs and resembles the human diseases in 
terms of characteristics 
85
, however, it is not androgen dependent in dogs 
86
.  The high 
cost, long gestation period and difficulty of genetic manipulation often make dogs an 
unrealistic model 
87
.  Several strains of rat also naturally develop prostate cancer 
including Dunning, Copenhagen and Wistar 
88
.  However, these tumors are rare, vary in 
phenotype and lack metastases making them less than ideal as experimental models 
87
. 
 The mouse is currently one of the best and most commonly used models of 
prostate cancer 
87
.  Although prostate cancer does not occur naturally in  mice, they are 
as susceptible to cancer as humans 
89
.  The mouse genome is also 95% similar to that of 
humans and is relatively easy to genetically modify 
87
.  Finally, mice have short 
gestation, are relatively small, and easy to house and breed making them a useful 
candidate for experimental models.  Xenograft models are created in immunodeficient 
mice that are injected with human tumour tissue, or cell cultures 
90
.  Despite the utility 
of these models, the major concern is that the compromised immune system, required to 
allow growth of foreign tissue, may affect tumour progression  in these mice 
90
.   
 Genetically engineered mouse models of prostate cancer are mice inflicted with 
genetic modifications equivalent to those associated with the human disease 
88
.  The first 
published genetically engineered mouse model was the C3(1)-Tag model in 1994 
88
.   
This model was created by targeting the expression of the SV40 large tumour antigen 
(Tag) to the prostate by using a region of the C3(1) gene.  Male C3(1)-Tag mice 
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developed prostatic epithelial hyperplasia as early as 3 months of age, and the majority 
developed locally invasive tumours by 7-11 months of age.  The tumours in this model 
rarely metastasize 
88
.  The expression of Tag in this model was not specific to the 
prostate.  Two-thirds of the female mice developed mammary tumours associated with 
SV40 expression 
91
.   This strategy of expressing SV40 antigens to the prostate was used 
in several later models with more effective prostate targeting 
87
.   The LADY series of 
models consist of seven transgenic lines which are split into three groups based on when 
in the life cycle of the mouse neoplasia is attained  
92
.   The cancer in this model starts as 
small foci of hyperplasia and then proliferates outwards, followed by dysplasia, prostatic 
intraepithelial neoplasia (PIN), and finally adenocarcinoma.  This represents an ideal 
model of the stages of human prostate cancer, however, castration resistance and 
metastasis are not well modeled 
87
.  
 1.7.1   Transgenic ardenocarcinoma of mouse prostate (TRAMP) model 
The transgenic ardenocarcinoma of mouse prostate (TRAMP) shares many 
similarities with the human clinical prostate disease.  The TRAMP mouse develops 
spontaneous autochthonous prostate cancer with distant site metastasis and offers a 
realistic molecular and physical comparison to the human disease 
93
.  The tumours 
originate and develop within the prostate gland of the animal.  Tumours cannot be 
palpated or visualized in the animal prior to imaging, unlike many xenograft models.  
Molecularly, the TRAMP model displays PIN prior to tumour formation 
94
.
 
The tumour 
development begins as androgen-dependent then progresses to androgen-independent 
similar to the human disease 
95
.  The major disadvantage with the TRAMP model is that 
it most often develops cancer with neuroendocrine (NE) origin 
96
.  Some neuroendocrine 
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markers are found in the human disease, however, the majority of cells in human 
prostate cancer are epithelial 
87
. 
 Adenocarcinoma is an invasive, malignant neoplasm of the epithelium with 
glandular formation and lacks the light microscope features of neuroendocrine 
differentiation  
87
.  Adenocarcinoma in the human is classified as well, moderation, 
moderately-poor or poorly differentiated.  In genetically engineered mice, the 
classification scheme is the same excluding moderately-poor differentiated 
93
.  Well 
differentiated refers to the majority of the tumour having well-formed glands.  
Moderately differentiated refers to tumours with mostly glands but some foci mixed in 
showing gland fusion or solid areas.   Poorly differentiated refers to tumours where the 
invasive foci are mostly nests or solid sheets, but gland formation is still focally seen 
97
. 
1.8 Rational, hypothesis and specific aims 
1.8.1  Rationale  
Prostate cancer is a common disease among men in developed countries and, 
fortunately, has a relatively high survival rate provided diagnosis occurs in its early 
stages 
4
.   However, detection of the disease in its early stages remains unreliable due to 
inadequate detection techniques 
5
.  Furthermore, treatments of early-stage prostate 
cancer, when diagnosed, are often associated with adverse side effects 
21
.    New 
treatment options for early-stage prostate cancer which have minimal to no side effects 
are available 
8
, but lack adequate monitoring tools.  There is, thus, a growing need for a 
technique that is capable of diagnosing prostate cancer with high contrast and high 
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resolution as well as a technique for monitoring these new, preferable prostate cancer 
treatments. 
OA imaging has been demonstrated to acquire high contrast and resolution 
images in real-time 
28
.  This thesis addresses one of the major limitations with OA 
imaging of prostate cancer; the need to use planar detection geometry in prostate 
imaging, which is often associated with relatively lower resolution when operating in 
real-time 
50,51,55
.  Frequency analysis of OA signals, described herein, may offer a means 
of providing sub-resolution detail to low resolution OA images.   This could greatly 
enhance the applicability of OA imaging in prostate cancer detection and treatment by 
providing sub-resolution detail about the vasculature of the tumour (which is indicative 
of its aggressiveness), and physical changes that occur during treatment that indicate 
successful tumour destruction.   
This analytical technique could strengthen all OA imaging applications, 
especially those systems where the quality of resolution is limited by physical 
constraints, by providing complementary information to the current amplitude based 
analysis technique.   
1.8.2  Hypothesis 
Optoacoustic signal intensity and frequency spectrum are sensitive to 
physiological differences between healthy and neoplastic tissues, and to treatment-
induced physiological changes. 
1.8.3  Objectives 
38 
 
The main objectives of the current thesis were: 
1. Characterize the system specifications including contrast, resolution and 
sensitivity to identify optimal image acquisition parameters. 
2. Determine the OA image contrast and resolution of prostate tumours in a mouse 
model in vivo. 
3. Determine OA frequency analysis when monitoring treatment induced 
physiological changes in ex vivo tissues, which occur during LTT, in real-time.  
4. Measure the sensitivity of frequency based analysis of OA signals compared 
with amplitude based analysis to distinguish targets, and describe the 
complementary (e.g. subresolution) information that frequency based analysis 
may offer. 
5. Determine the relationship between the OA frequency metrics and biological 
tissue characteristics, such as size and density of OA targets, through phantoms, 
computer simulations and in vivo experiments. 
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CHAPTER 2 
OPTOACOUSTIC IMAGING SYSTEM CHARACTERIZATION 
 
 
“Not only is the Universe stranger than we think, it is stranger than we can 
think.” 
 
-Werner Heisenberg (1901-1976) 
picture from http://www.goodreads.com/author/show/64309.Werner_Heisenberg 
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2.1 Introduction  
The optoacoustic (OA) imaging system used in this study is a prototype system 
purchased from SENO Medical Instruments Inc. (San Antonio, TX).  Full 
characterization of the system had not been accomplished prior to this work.  The 
system is one of only three similar SENO prototype systems in the world and, therefore, 
has not been thoroughly characterized in literature.  Knowledge of the imaging system-
dependent features is imperative in order to correctly analyze the detected signals.  In 
order to properly set up experiments and have confidence in the results, it is important to 
understand the capabilities and limitations of any imaging system.  Specifically; its 
sensitivity, reproducibility, image accuracy and contrast 
1
.  These characteristics aid in 
determining such things as sample size, necessary target characteristics (i.e. size, 
composition, etc.) to optimize detection, and required recalibrations between 
acquisitions.   
The phantom studies described in this chapter were performed to gather such 
information and provide a basic reference of the system‟s response to target 
characteristics, so as to aid in the analysis of more complex data in the following 
chapters.  
2.1.1 Optoacoustic wave generation 
Theoretically, the OA signal increases linearly with increasing absorption 
coefficient of the target as describe by the equation below 
2
.  
                                                  aP                                                         [1] 
where μa is the absorption coefficient of the target, Γ is the Grűneisen parameter which 
is dependent on several physical characteristics of the target (e.g. thermomechanical 
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properties, stiffness, etc.) , and Φ is the laser fluence (i.e. energy delivered per unit    
area) 
3,4
.   
Absorption coefficients of different biological tissues and fluids often vary more 
drastically than the differences between their Grüneisen parameter, allowing OA 
imaging to differentiate among tissue types based on their absorption 
5
.  This study 
focuses on absorption coefficients for rodent tissues/organs.   Examples of published 
absorption coefficients in different tissues are presented in Table 2.1, and range between 
approximately 0.2 and 0.6 cm
-1
.  
2.1.2 Sensitivity, theory validation and reproducibility 
Sensitivity describes the minimum signal that the system can detect above 
background noise.  In biological tissues, the primary determent of OA wave strength is 
the absorption coefficient.  Therefore, the sensitivity can be determined by finding the 
target with the minimum absorption coefficient which can be detected by the OA 
system.  
The theoretical relationship between the absorption coefficient of a target and the 
generated OA signal was validated.  This was accomplished by comparing the average 
signal strength of a target to the theoretical signal strength of that target.   The 
repeatability (or precision) of a system, is the degree to which repeated measurements 
show the same results 
6
.  The repeatability may be described by the variation in the OA 
signal strengths associated with a target which was imaged numerous times under 
unchanged conditions. 
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Table 2.1:  Absorption coefficients in mouse tissues 
7–9
. 
Tissue Wavelength (nm) Absorption coefficient  
(cm
-1
) 
Mouse Muscle 700 0.23 
Mouse Lung 700 0.35 
Mouse Heart 700 0.11 
Mouse Liver 700 0.45 
Mouse Kidney 700 0.12 
Mouse Stomach 700 0.21 
Blood (oxygenated) 780/1064 0.35/0.30 
Blood (de-oxygenated) 780/1064 0.60/0.05 
Mouse skin 1064 0.20 
Mouse Spleen 1064 0.18 
Human prostate 786 0.30 
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2.1.3 Optoacoustic image accuracy 
Optoacoustic resolution is largely affected by the frequency and geometry of the 
detection transducer.  The transducer of the SENO OA system is an annular array 
transducer consisting of eight concentric piezoelectric ring sensors (See Section 1.4).  
The achievable resolution of each transducer in the array is dependent upon the depth, z, 
of the optoacoustic source, as well as on the diameter and width of the transducer 
10
.    
Resolution is the minimum distance between two objects that a system can still 
determine the targets as separate 
11
.  The SENO OA system is a low resolution system 
due to the transducer characteristics and its central frequency of 5 MHz, however, for 
this study we are interested in its ability to accurately predict target size (i.e. its 
accuracy).  Accuracy is defined as the ability of the system to accurately predict target 
size. 
2.1.4 Optoacoustic image contrast 
Contrast is defined as the difference between the signal strength on target 
compared with surrounding signal 
12
.  The variation among the Grüneisen parameters  of 
biological tissues, at wavelengths of the SENO OA system (775 and 1064 nm) and at 
body temperature (38 °C in rodents), are minimal compared to variations in their optical 
absorption properties
1,13
.  Contrast in tissue is, thus, driven largely by optical absorption.   
Understanding the relationship between the generated signal amplitude and the target‟s 
optical absorption will allow for the prediction of the contrast that can be achieved in 
different tissues/organs compared with surrounding tissues (based on their published 
absorption coefficients) 
1
.   
2.1.5 Tissue-mimicking phantoms 
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When testing a system's performance, the use of in vivo or ex vivo tissue samples 
is ideal.  However, the use of tissue is often impractical for testing significant issues 
with respect to the intrinsic performance of the device (signal, detector and processing 
precision and repeatability).   A highly reliable alternative is the use of tissue-mimicking 
phantoms.  Although phantoms do not reflect the complexity of tissue, they provide an 
accurate way of testing parameters and modeling and evaluating theoretical assumptions 
of important tissue features, such as optical absorption and scattering. 
Over the past few decades many different types of phantoms have been 
developed for OA imaging, each with their advantages and disadvantages 
8,14
.  The 
composition of the optimal phantom depends on its intended use and the physical and 
biological characteristics to be mimicked.  In laboratory use, the most common phantom 
materials are; gelatin 
15
, agar 
16
, polyester 
17
, epoxy 
18
 and resin 
19
.  These materials 
provide a soft medium which is biologically and biochemically comparable with organic 
molecules 
19
.  Alone, these materials have minimal scattering and absorption 
coefficients, therefore absorbing and scattering materials may be added to the phantom 
during preparation 
17
.    
The OA wave generated is affected by the absorption coefficient, scattering 
coefficient, anisotropy coefficient, and mechanical and surface properties 
3
.  Therefore, 
it is imperative that these characteristics of the phantom can be varied to mimic those of 
in vivo tissues at the wavelengths of interest (i.e. 775 nm and 1064 nm).    The 
mechanical and surface properties should be similar to those of tissue (e.g. Young‟s 
modulus between 0.35 to 3.15 kPa) 
20
, and the optical properties (absorption and 
scattering coefficients) can be chosen to mimic a „generic‟ overlaying tissue.  Of the 
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phantom materials presented, gelatin and agar have the most similar acoustic and 
mechanical properties to tissues 
15,16
.  The OA target (mimicking the optical properties 
of the biological target) can then be embedded into the phantom material.     
2.1.6 Optical scatters and absorbers 
The most common scatterers are titanium dioxide (TiO2) particles, lipid-based 
scatterers (e.g. milk, intralipid, etc.), and polymer microspheres 
17
.  Titanium dioxide is 
available at a relatively low cost (compared with some lipid-based and microsphere 
scatterers) 
17
, and is the most commonly used scatterer due to its wide availability .  The 
main disadvantage of TiO2 is its powder form that can settle quickly in liquid phantoms 
17
.  Intralipid (fat emulsion of soy bean oil, egg phospholipids, glycerin and water) is a 
common lipid-based scatterer which is slightly more expensive than TiO2, however it 
provides better reproducibility than TiO2 
21
.  Intralipid also disperses easier making for a 
more homogeneous phantom.   
Polymer microparticles are biologically similar to tissue scatterers.  They are 
also very common and provide a scattering material which is highly reproducible 
17
.   
Their main disadvantage is their high cost compared with other scatterers.  A summary 
of the benefits and limitations of commonly used scatterers is presented in Table 2.2.  
The addition of absorbers can provide the phantom with specific absorption coefficients 
which is essential for mimicking tissues.  The most common choice of absorbers are ink 
and hemoglobin 
22
.   Black Pelikan ink is a common absorber as it has negligible 
scattering and provides a simplistic way of obtaining an almost constant absorption 
spectra within the wavelength range of 700-1100 nm 
21,23
.   Hemoglobin provides a 
more realistic tissue  
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Table 2.2:  Advantages and disadvantages of common scatterers used in optoacoustic 
phantom construction. 
Scatterer Advantages Disadvantages 
Milk (lipid-based) Readily available  Not highly reproducible 
between samples 
Oil/fat/lipid (lipid-based) Readily available  Must be emulsified.  
Blended reproducibly 
Intralipid (lipid-based) Reproducible source of 
lipid solution.  
Relatively high cost 
compared with other lipid-
based scatterers 
Polymer microspheres  Provide stable and precise 
scattering 
High cost compared with 
other scatterers 
Titanium dioxide  Readily available. Provides 
calibrated scattering 
Settling often occurs  
  
 
 
 
 
 
 
 
55 
 
 
absorption spectrum; however, it does not offer a constant absorption spectrum.  Its 
absorption varies significantly between wavelengths within 700-1100 nm. 
 In this study, the characteristics and capabilities of the OA system are 
investigated.  Knowledge of the system-dependent characteristics, namely the sensitivity 
and repeatability, will allow for optimal imaging protocols to be constructed for this 
system.  Furthermore, knowledge of the image contrast and accuracy will aid in 
understanding and quantifying the generated OA signals from more complex tissue 
targets. 
2.2 Materials and Methods 
2.2.1 Optoacoustic image acquisition 
The imaging system (Seno Medical Instruments Inc., San Antonio, TX) consists 
of an Nd:YAG pumped Ti:Sapphire laser operating at 775 nm and an 8 element 
concentric annular array piezoelectric transducer (Figure 2.1).  The piezo-electric 
detection system consisting of 8 elements offers dynamic focusing capabilities which 
leads to a reduction in image artifacts compared to spherical detectors, and allows for 
structures lying on the axis within a wide depth range to be localized 
10,24
.     
The transducer has a nominal central frequency of 5 MHz, with a -6dB 
bandwidth of 60%, a focal point at 25 mm, a focal length of 10 mm, and a focal width of 
0.5 mm.  The bifurcated optical fiber bundle delivered 6 ns pulses at a 10 Hz repetition 
rate and 20 mJ of energy per pulse.  The step size was chosen to produce the optimal 
lateral accuracy (directly related to step size) while maintaining a reasonable acquisition 
time (directly related to step size).  A constant TGC was used to ensure that comparisons  
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a)  
b)  
Figure 2.1:  Seno optoacoustic imaging system a) side view, b) top-down view.  Laser 
optical path intercepts at 25 mm from the transducer which is located beneath a camera 
used for image positioning.  
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among images would be reliable.   A laser fluence of 0.2 W/cm
2 
was chosen to reflect a 
relative energy used in vivo which would allow for optical penetration depth of over 1 
cm 
25,26
, while remaining within the American National Standards Institute (ANSI) 
guidelines 
27
.     
2.2.2 Optoacoustic image contrast  
The Grüneisen parameter and the laser fluence were kept constant by using the 
same thin walled glass tubes for each of the targets, and constant laser energy during all 
experiments.  Therefore, the variation in the OA signal amplitude was affected only by 
the variation in the absorption coefficient of the target. 
Black Pelikan ink (Pelikan 4001, Brilliant-Schwarz) was added to distilled water 
in varying concentrations to obtain solutions with specific absorption coefficients.  A 
cuvette was filled with the solution and the absorbance (or transmittance) was measured 
using a spectrometer (Spectronic 20D, Thermo Fisher Scientific Inc, Wisconsin USA) 
according to the manufacturer's instructions.  The absorption coefficient (which is 
wavelength dependent) was calculated using the Beer-Lambert Law.   
                                                Aλ=lccελ                                                                [2] 
Where Aλ is the absorbance (measured by the spectrometer), l is the path length 
of the spectrometer (1 cm), cc is the concentration of the solution, and ελ is the molar 
extinction coefficient.   The absorption coefficient is the product of the molar extinction 
coefficient and the concentration.  Dye was added until the absorption coefficient of the 
solution reached the desired level. The uncertainty in the spectrometer reading is    
±10% 
28
. 
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Thin walled glass tubes (3 mm diameter and 0.01 mm wall thickness; Charles 
Supper Company, MA) were filled with solution and secured vertically on a holder in 
the OA system water tank.  Images of a 5 mm x 5 mm area, centered on each tube, were 
obtained (Figure 2.2).  Contrast was defined as the average signal amplitude within a 1.5 
mm x 1.5 mm region of interest (ROI) centered on the tube compared to two 0.75 mm x 
1.5 mm ROI‟s (for a total ROI size of 1.5 mm x 1.5 mm) 0.25 mm from the edge of each 
side the tube.   
2.2.3 Theory validation and repeatability 
The tubes contained solutions of varying absorption coefficients (0.3, 0.4, 0.5, 
0.6, 0.7, 0.8 and 0.9 cm
-1
).  Theoretically, OA signals would increase linearly with 
increasing absorption coefficient (assuming the other parameters were unchanged).  
Therefore, the theory was validated by measuring the linearity of the signals versus the 
absorption coefficients (i.e. R
2 
, the coefficient of determination) 
29
.  Measurements were 
performed three times each day for three days (for a total of nine repetitions to 
investigate the system repeatability) for each absorption coefficient.  Based on power 
analysis, this replication rate was estimated to achieve sufficient power 
30
.  At the end of 
each of the three days the system and laser were shut off.  The solutions were mixed on 
the first day and kept in sealed glass containers that were stored in a light-proof box to 
diminish optical degradation of the solutions by ambient light 
31
.   
To investigate the effect of target size, a subset of these measurements were 
performed using 5 mm diameter, thin walled glass tubes filled with the same solutions.  
To examine the effect of overlaying tissue, identical tubes were also embedded into 
tissue-mimicking phantoms. 
59 
 
 
 
 
 
 
 
 
Figure 2.2:  A glass tube (3mm diameter) filled with an absorbing solution and secured 
to a holder which will be placed into the OA imaging system waterbath during image 
acquisition.  Images of a 5 mm by 5 mm area, centered on the tube and extending 1 mm 
off the sides of the tube, were obtained. 
 
 
 
 
 
Glass 3 mm diameter
tube filled with
absorbing solution
Holder
Imaged area
(5x5 mm)
60 
 
2.2.4 Distance-from-transducer 
The “distance from transducer” that a target is positioned is very important when 
using a focused transducer and can have a great affect on the above-mentioned 
parameters.  A focused transducer is more sensitive to signals originating closer to its 
focal point (at 25 mm for our system).  The signal variation with target distance from the 
transducer was investigated by measuring the maximum OA signal amplitude obtained 
from a tube filled with a solution with a 0.6 cm
-1
 absorption coefficient at three distances 
from the transducer (20, 25, and 30 mm). These images were acquired in immediate 
succession.  This was repeated three times on three consecutive days for a total of 9 
images at each distance.  Based on power analysis, this replication rate was estimated to 
achieve sufficient power 
30
. 
2.2.5 Tissue-mimicking phantoms 
Tissue-mimicking phantoms were constructed using gelatin derived from porcine 
skin (Sigma-Aldrich Co., St. Louis, MO).  Gelatin is one of the most commonly used 
phantom materials for ultrasound and spectroscopy imaging system characterization and 
calibration 
19,32
.    
Table 2.1 describes the large variation among published absorption and 
scattering coefficients in biological tissues 
8
. However, since the aim of the phantom 
produced in this study was to mimic a 'representative' soft tissue in a rodent, these 
values were used to assist in the development of phantom parameters.  Phantoms were 
designed to optically mimicked mouse skin and muscle tissue which have averaged 
published absorption and scattering coefficients of 0.2 cm
-1
 and 10 cm
-1
 respectively at 
775 nm, and approximately 0.2 cm
-1
 and 20 cm
-1
 at 1064 nm 
8
.   
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2.2.6 Gelatin Phantom Preparation  
Two hundred milliliters of water was placed in a 1000 mL beaker, and covered 
with a glass plate to reduce evaporation.  A hotplate was used to bring the water to 
approximately 80
o
C and maintain that temperature during mixing.  One ml of Pelikan 
black ink was added to the water and allowed to stir for several minutes.   Intralipid 20% 
(10 mL; Signal-Aldrich Co., Oakville, ON) was then slowly added to the mixture and 
stirring continued for a minimum of 10 minutes to ensure homogeneity of intralipid 
throughout the solution during solidification.  Twenty grams of Knox® gelatin was 
slowly added to the solution.  The solution stirred until the gelatin was fully dissolved 
(about 10 minutes).  The temperature of the hotplate was reduced to 25 °C.  The gelatin 
solution was then poured into 4 cm by 4 cm by 2 cm square moulds.  The moulds were 
kept at 4
o
C overnight 
23
.   
Thin-walled, 3 mm diameter glass tubes were filled with an absorbing solution 
of ink in water, with an absorption coefficient of 0.8 ± 0.1 cm
-1
 at 775 nm (mimicking 
highly absorbing biological tissue, such as a tumour) 
8
.  Tubes were secured into the 
moulds at the desired depths, 0 mm (surface), 3 mm and 5 mm, and the liquid gelatin 
solution was then poured into the mould.  Once solidified, phantoms were removed from 
the moulds (Figure 2.3), placed in air-tight bags, and stored at 4
o
C for up to 3 days.  
Images of the embedded tubes were acquired using the same imaging parameters and 
protocol as was used for the un-embedded tubes described in section 2.2.1 except the 
imaging area was increased to 10 mm by 10mm (the ROI used for analysis remained the 
same). 
 2.2.7 Double Integrating Sphere System 
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Figure 2.3:  A representative tissue-mimicking phantom secured to a holder placed into 
the OA system waterbath during image acquisition.  The gelatin-based phantom was 
constructed to mimicking mouse muscle and skin and the embedded glass tube filled 
with highly absorbing solution (0.8 cm
-1
) mimics a highly vascularized tumour. 
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The goal was to construct a phantom with μa = 0.2 cm
-1
 and μs=10 cm
-1
 at 775 
nm, and μa = 0.2 cm
-1
 and μs= 20 cm
-1
 at 1064 nm to simulate generic murine  
overlaying tissues 
8
.  Samples of each batch of gelatin solution used in the phantom 
development were sent to Ryerson University, Toronto ON where the optical properties 
were measured using the double integrated sphere (DIS) approach 
33
.   
Accurate determination of the optical properties was needed to understand and 
predict light propagation and distribution within the gelatin material. The diffuse 
reflectance (Rd), diffuse transmittance (Td), and the collimated transmittance (Tc), were 
measured for each gelatin sample.  To measure the optical properties, a sample is placed 
between two identical integrating spheres of 30.5 cm (12 in.) diameter with a circular 
sample window of 25 mm diameter and illuminated with a white light operating at 7 W 
(Ocean Optics, Dunedin, FL, USA). Light was focused onto the sample using a set of 
optics that collimate and produce a 5 mm beam diameter. Rd and Td were collected in 
the first and second sphere respectively and Tc was collected by capturing the 
collimated transmittance at a distance of 100 mm beyond the second sphere, as shown in 
Figure 2.4. Measurements were collected using an optical spectrometer.  Rd and Td were 
measured relative to a baseline signal using a 99% reflecting plate (Sphere 30 Optics, 
SG2052, Concord, NH, USA) that was placed at the sample aperture while Tc was 
determined relative to 100% transmission (i.e. with no sample). 
From these three measured parameters a unique relationship exists from which 
the absorption coefficient and scattering coefficient can be derived 
34
.  Different 
methods are available to compute the optical properties on measured values, such as the 
inverse adding doubling algorithm (IAD) which was used in this study 
35
, and the more  
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Figure 2.4: Experimental setup of DIS using a white light source. DR, DT, DC are the 
locations where Rd, Td, and Tc are measured from respectively.  Adapted from 
Castelino 2008 
34
. 
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sophisticated but highly computationally intensive method using Monte Carlo (MC) 
simulations where the measured values are correlated using an inverse MC 
36,37
. 
2.2.8 Data Analysis 
A Matlab®-based script was developed to analyze the OA signal. The Hilbert 
transform was applied to all signals. The maximum of the Hilbert transform along each 
signal was defined as the front surface of the tube.  The area under each signal curve 
was integrated and this was defined as the integrated area under the curve.  The average, 
baseline corrected, amplitude within a 1.5 mm by 1.5 mm region of interest (ROI) 
centered along the front surface of the tube was defined as OA signal amplitude.     
The width of the tube in the axial direction (axis of the transducer) was measured 
as the distance between the two „peaks‟ in the signal (peak to peak distance). The width 
in the lateral direction (perpendicular axis to the transducer) was determined by applying 
the Full Width Half Max (FWHM) approach to the acquired OA signals 
38
.   
Standard student t-tests were employed to test for significant differences between 
the generated data in this chapter.  Repeated trials were accounted for by an ANOVA 
with repeated measures when necessary. 
2.2.9 Image Formation Methods 
 The axial data were compressed to, or presented as two dimensions to give the 
optimal lateral size predictions.  For the compression techniques, only data from a time 
window corresponding to a 0.5 cm depth (centered on the tube) was used for analysis.   
Three techniques were analyzed.   
1. Integrated amplitude projection (IAP) 
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The signal values were integrated within each time window, at each signal 
acquisition position, and projected onto a 2D plane as the corresponding pixel 
value in the final two-dimensional image.   
2. Maximum intensity projection (MIP) 
The maximum signal value within each time window at each position was 
identified.  This value was projected onto a 2D plane as the corresponding pixel 
value in the final two-dimensional image. 
3. Two-dimensional slices 
Several single 2D slices (at the front surface, center and back of the tube) were 
analyzed.  There may be some important volumetric information in this data 
which may be lost during image compression. 
Two-dimensional images were constructed using the above three different techniques 
and the image contrast and accuracy were measured and compared to determine the 
optimal technique. 
2.3 Results 
2.3.1 Image formation techniques and associated contrast and accuracy 
 The three optoacoustic image formation techniques described in the Materials 
and Methods section (2.2.9) are represented in Figure 2.5.  Representative two-
dimension OA images of 3 mm glass tubes filled with a solution of 0.8 cm
-1
, acquired 
with 775 nm illumination, are shown.  Images of the tube at 0 mm (on the surface of the 
tissue-mimicking phantom) and embedded at a depth of 3 mm in a tissue-mimicking 
phantom described previously are shown.    
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Figure2.5:  Representative optoacoustic images of integrated and maximum signal 
amplitude projections and single slices in the lateral direction of a 3 mm glass tube filled 
with a solution of absorption coefficient of 0.80 ± 0.01 cm
-1
.  Front surface of the targets 
were placed at 25 mm from the transducer.  Images are shown of the tube at depths of 0 
mm (on surface of phantom) and at 3 mm in phantom.  Amplitude scales of each image 
are set to the maximum and minimum amplitude value and vary from maximum of 0.1 
(b) to >1 (c, e). Images at 0mm are 5 mm by 5 mm, images at 3 mm are 8 mm by 8 mm 
Images acquired with 775 nm illumination. 
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A representative OA signal (Hilbert transformed) and a one-dimensional IAP of 
a 3 mm tube filled with a 0.6 cm
-1
 solution onto a lateral plane are shown below (Figure 
2.6). Width predictions were calculated along both the axial direction (peak to peak) and 
lateral direction (full width half max).  The prediction results are shown in Figure 2.7.  
Target width predictions in the axial direction (along the axis of the transducer) had a 
mean of 1.8 mm and a standard deviation of 0.8 mm and, thus, underestimated with the 
true width by approximately 30%.  The width predictions in the lateral direction (axis 
perpendicular to the transducer), using FWHM, had a mean of 3.0 mm and a standard 
deviation of 0.5 mm. 
 Contrast measurements and width predictions associated with the three 
compression techniques (see Section 2.2.8) are described in Table 2.3.  Results are from 
signals acquired with 775 nm illumination.  
Contrast values were greater on the maximum intensity projection images and 
the single slice images, averaging 3.9 ± 0.8 and 3.8 ± 0.9 respectively, compared to the 
IAP images whose contrast values averaged 2.0 ± 0.5.  Target width predictions from 
the IAP images agreed with the true tube dimensions with standard deviations of 
approximately 3%.  Maximum signal projection and slices had associated standard 
deviations of approximately 15% .  Although contrast is lower on the IAP (yet still high 
compared with ultrasound contrast which is often less than 1 
39
), the accuracy of the 
width predictions (with overlaying scattering medium) was deemed crucial for future 
experiments.  Therefore, based on these results all further compressions were 
accomplished using the IAP technique. 
 
 
69 
 
 
 
 
 
 
 
 
 
Figure 2.6: Representative a) optoacoustic signal, acquired with 775 nm illumination, 
generated by a thin-walled glass tube filled with a solution with an absorption 
coefficient of 0.6 cm
-1
 and b) OA integrated amplitude, projected onto the lateral plane 
(direction perpendicular to the transducer), generated by the same 3 mm tube.   
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Figure 2.7:  OA predicted target widths acquired with 775 nm illumination, a) in the 
lateral direction (perpendicular to the transducer axis) measured using full width half 
max of the integrated amplitude projection, b) in the axial direction (parallel to the 
transducer axis) measured as the distance between the front and back peaks in the OA 
signal (peak to peak).  Horizontal lines indicated ± 10%.   
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Table 2.3:  Contrast and width predictions of an absorbing target embedded at three 
depths in a gelatin phantom.    Three image compression approaches were investigated 
for each optoacoustic image (integrated signal, maximum signal and slice).  
Uncertainties are presented as one standard deviation (N=9).  Images acquired with 775 
nm illumination. 
Depth 
of 
target 
(mm) 
Contrast 
(integrated 
signal) 
Contrast  
(maximum 
signal) 
Contrast  
(single 
slice) 
Width  
(integrated 
signal, mm) 
Width 
(maximum 
signal, mm) 
Width 
(single 
slice, 
mm) 
0 1.8±0.4 4.7±0.2 3.3±0.3 3.3±0.1 3.1±0.4 3.2±0.4 
 
3 2.7±0.3 4.0±0.1 5.5±0.8 3.3±0.1 3.0±0.4 3.0±0.4 
 
5 1.5±0.2 2.9±0.3 2.6±0.6 3.1±0.2 3.0±0.4 3.2±0.5 
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Optoacoustic signal amplitudes and axial widths of the thin-walled glass tubes 
with 3 mm diameters filled with absorbing solution (with an absorption coefficient of 
0.8 cm
-1
) and embedded at depths of 0 mm (surface), 3 mm and 5 mm in gelatin, 
acquired with 775 nm illumination, are summarized in Table 2.4.   
2.3.2 Optoacoustic transducers’ focus 
 The focal point of the OA system's transducer is located at 25 mm from its front 
surface (Figure 2.8a).  The transducer has a focal width of 0.5 mm and focal length of 10 
mm.  Figure 2.8b shows the integrated OA signal amplitude from a tube (filled with a 
solution which an absorption coefficient of 0.6 cm
-1
) as a function of distance from the 
tube‟s front surface to the transducer.  For both 775 nm and 1064 nm illuminations, the 
amplitude of the signals decreased by approximately 50 % at 20 mm and 30 % at 30 mm 
compared with the signal at 25 mm (transducer focal point). 
These results demonstrated the necessity for accurate placement of targets in the 
OA imaging system.  All further measurements were acquired with the target placed at 
25mm from the transducer surface.  
2.3.3 System sensitivity, repeatability and theory validation 
The two graphs in Figure 2.9 show the integrated OA signal amplitude and the 
absorption coefficient of the solution inside the tube. All measurements were taken with 
the front surface of the tube placed 25 mm from the transducer.   
The OA signal versus target optical absorption coefficient was fit to a line and the 
correlation coefficients of 0.9112 and 0.9178 at 775 nm and 1064 nm illumination 
indicate a strong linear correlation.  The two illuminations have the same relative slope  
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Table 2.4:  Optoacoustic integrated signal amplitude generated by 3 mm tubes filled 
with absorbing solution at three depths in gelatin phantoms and associated axial width 
predictions.  Average values ± standard deviations are presented (N=9).  Images 
acquired with 775 nm illumination. 
Depth of 
tube (mm) 
OA signal amplitude 
(a.u.) 
Axial width (mm) 
0 0.0098 ± 0.0002 1.8±0.3 
3 0.0077 ± 0.0005 3.1±0.1 
5 0.0090 ± 0.0005 3.3±0.1 
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Figure 2.8:  a) Schematic of the focal properties of the transducer in the SENO 
optoacoustic imaging system, and b) Integrated optoacoustic signal amplitudes 
generated by a 3 mm tube filled with a solution of 0.6 cm
-1
 absorption at three distances 
from the transducers‟ surface (N=3). 
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Figure 2.9:  The integrated optoacoustic signal amplitude as a function of absorption 
coefficient showing a linear relationship with an R
2
 value of 0.9112 and 0.9178 for 
775nm and 1064nm illumination respectively. 
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as well.  Theoretically, the OA signal values would fall on a linear line.  A standard 
student t-test found significant differences between targets with absorption coefficients 
differing by greater than 0.2 cm
-1 
for both illuminations.  A two-way ANOVA was also 
used to determine that there were no significant differences between the repeated data 
generated on the same day and on consecutive days (Figure 2.10).   Thus, the system 
also has good repeatability within and between days.   This also demonstrates that the 
system can detect targets with absorption coefficients down to 0.3 cm
-1
.   
2.3.4  Target size considerations 
  A subset of OA images were acquired of 5 mm thin glass tubes filled with 
solutions of different absorption coefficients.  The data analysis performed was identical 
to that used for the 3 mm glass tube study.  Table 2.5 presents the integrated OA signal 
amplitude and width predictions of the 5 mm tubes.   
There were no significant differences between the amplitude of the generated 
OA signal of a 3 mm and 5 mm glass tube containing liquid with the same absorption 
coefficient.  Width predictions in the axial direction underestimated with the true width 
by approximately 25%  with an average predicted width of 3.7 mm and a standard 
deviation of 0.2 mm.  The width predictions in the lateral direction using FWHM, were 
on average 5.5 mm and a standard deviation of 0.5 mm. 
2.4  Discussion and Conclusions 
 This study aims to characterize the SENO OA imaging system by defining the 
following characteristics:  system sensitivity and repeatability, and image contrast and 
accuracy (in this study, defined as the accuracy of the images to predict the true target 
width).  The results demonstrate the necessity for proper image compression methods to  
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Figure 2.10:  Boxplots represent the integrated optoacoustic signal amplitudes 
generated by solutions with absorption coefficients ranging from 0.3 to 0.9 cm
-1
 on 3 
consecutive days for both 775 nm and 1064 nm illumination (N=9).  A two-way 
ANOVA demonstrated that there were no significant differences between days (p<0.05).   
The red center line represents the mean value, the blue box represents one standard 
deviation and the black bars represent the spread of the data.  Red crosses represent 
outliers in the data. 
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Table 2.5:  Integrated optoacoustic signal amplitudes and predicted widths (axial and 
lateral) generated by 5 mm thin-walled glass tubes filled with solutions of varying 
absorption coefficients.  Average values ± standard deviations are presented (N=9). 
Absorption 
coefficient 
(cm-1) 
±10%  
Illumination 
wavelength 
(nm) 
OA signal 
amplitude 
Axial width 
(peak to peak) 
Lateral width 
(FWHM) 
0.3 775 0.005±0.005 3.88±0.01 5.4±0.2 
0.3 1064 0.005±0.001 3.92±0.01 5.5±0.2 
0.6 775 0.008±0.004 3.4±0.02 5.6±0.1 
0.6 1064 0.009±0.001 3.50±0.05 5.6±0.2 
0.9 775 0.015±0.001 3.85±0.07 5.4±0.1 
0.9 1064 0.016±0.001 3.85±0.08 5.4±0.1 
Average   3.7±0.2 5.5±0.5 
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be used, as well as the importance of overlaying scattering material for accurate width 
predictions.  Three different compression methods were compared which compressed  
three-dimensional data to two-dimensions images.   Furthermore, this study 
demonstrated the relatively large effect that the target positioning with respect to the 
transducer has on the detected signal strength. 
Three different compression techniques were investigated in this study.  
Predicted tube widths measured in the axial direction (along the axis of the transducer) 
were underestimated by more than 1 mm (40%) with a standard deviation of 0.3 mm 
when there was no overlaying scattering medium (i.e. the tube was not embedded in a 
phantom).  Width measurements in the lateral direction (along the axis perpendicular to 
the transducer) agreed with the true width with standard deviation of 3% for IAP images 
and up to 15% for slices and MIP images.  Contrast was reduced in the IAP compared to 
the MIP and single slices, however, the IAP approach was chosen based on its more 
accurate size predictions which were deemed crucial for future experiments.  Similar 
results were found when imaging 5 mm glass tubes.  When overlaying scattering 
medium is introduced the axial width measurements agreed with the true width within 
0.3 mm (10%).  Future in vivo and ex vivo targets will always have overlaying scatters.  
Other, similar systems presented in literature achieve accuracies of approximately 0.1 to 
1 mm 
38,40,41
.  Based on these results, we conclude that the OA system can accurately 
predict target size within 10%, when there is overlaying scattering medium, using peak 
to peak and FWHM analysis of IAP images.  
The transducer's focus had a large impact on the detected OA signal strength. 
Signal strength decreased by almost 50% and 30% with the target placed at -5 mm and 
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+5 mm, respectively from the transducer‟s focus.  The transducers focus is where we 
would expect the highest signal to be obtained from any given target.  The OA laser is 
delivered by two bifurcated fibers which are positioned so that the beams intersect at 
approximately 25 mm (the transducers‟ focus).  The combination of these two system 
characteristics causes the quick drop off in signal outside the focal point of the 
transducer. 
The OA signal amplitude increased linearly, on a one to one basis with the 
absorption coefficient as expected give the OA pressure equation.  The linear fit of the 
data has a high R
2
 value validating the associated theoretical relationship 
42
.  The slope 
of the fit is approximately 1 at both 775 nm and 1064 nm illumination.  Targets with 
absorption coefficients of as low as 0.3 cm
-1
 were detected indicating that the system has 
sensitivity adequate for detecting highly vascularized tissues (often with absorption 
coefficients greater than 0.3 cm
-1
 in the near infrared range 
7
).  Targets with absorption 
coefficients which differ by greater than 0.2 cm
-1
 could be differentiated based on 
statistical tests performed on data from Figure 2.9.  The absorption coefficient of normal 
human prostate tissue (the absorption of mouse prostate as these wavelengths is not 
well-known) at 786 nm is approximately 0.3 cm
-1 9
, while highly vascularized tumours 
often have very high absorption coefficients, in the near infrared range, greater than 1.0 
cm
-1 38
.  Thus, OA imaging should be able to detect a tumour from background prostate 
tissue based on their respective absorptions.  Therefore, based upon the results of this 
study we conclude that the OA imaging system used herein will be capable of 
differentiating normal tissue from highly vascularized tissue.  Images that were acquired 
of identical targets at different times (within and between 3 days) showed no significant 
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differences between the generated signal contrasts.  This demonstrates that the system 
has good repeatability up to three days.  However, the variation among the signals 
produced by targets with the same absorption coefficient (Figure 2.9), as well as the 
variation among the predicted axial and lateral widths (Figure 2.7) was relatively high.  
Variations up to 25% between signals generated by tubes with the same absorption 
coefficient were observed (Figure 2.9).  Variations up to 30% in the width predictions 
were also observed (Figure 2.7)   This is very important as future studies will involve 
imaging targets several days apart.  Although the system variation between days may 
not affect the generated signals, the variation among the images may be high.  This may 
necessitate larger sample sizes and larger signal averaging to be performed to ensure our 
results are valid. 
 There was no significant difference between the integrated OA signal amplitudes 
generated by the 3 mm and 5 mm glass tubes (containing solutions with the same 
absorption coefficients) or the differences are beyond the sensitivity of the system.  As a 
result, only a subset of absorption coefficients (3 rather than 8) were investigated using 
5 mm diameter tubes.  Thus, small changes in the target size do not affect the OA signal 
significantly compared with changes in its absorption coefficient.  Although the 
amplitude of the OA would theoretically increase with target diameter 
42
, the sensitivity 
of this system was not capable of distinguishing the two sizes based on amplitude. 
The results of this study partially characterized the SENO OA system, and 
highlight some of the OA system-dependent features.  The sensitivity and repeatability 
of the system will aid to set up future experiments by; describing the systems 
capabilities to detect and differentiate targets based on their absorption coefficients, 
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allow sample size calculations to be performed, etc.   Image contrast and accuracy were 
determined for three image compression techniques.  The preferred image compression 
technique was chosen based on these parameters.  The information acquired may be 
used to aid in developing more sophisticated imaging protocols for future studies using 
this specific OA system, and serves as a reference point when analyzing more complex 
tissue data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
83 
 
References 
1. Xu, X.-H. & Li, H. Photoacoustic imaging in biomedicine. Physics - Beijing 37, 
111–119 (2008). 
2. Folkman, J. & Kalluri, R. Cancer without disease. Nature 427, 787 (2004). 
3. Larin, K. V, Larina, I. V & Esenaliev, R. O. Monitoring of tissue coagulation 
during thermotherapy using optoacoustic technique. Journal of Physics- London 
38, 2645–2653 (2005). 
4. Wang, L. V Ultrasound-mediated biophotonic imaging: A review of acousto-
optical tomography and photo-acoustic tomography. Disease markers 19, 123–
138 (2003). 
5. Wang, L. V & Hu, S. Photoacoustic tomography: in vivo imaging from 
organelles to organs. Science 335, 1458–62 (2012). 
6. Progress in quantitative coronary arteriography. 155, (Springer Netherlands: 
Dordrecht, 1994). 
7. Wang, G. et al. In vivo mouse studies with bioluminescence tomography. Optics 
Express 14, 7801 (2006). 
8. Cheong, W.-F., Prahl, S. A. & Welch, A. J. A review of the optical properties of 
biological tissues. SPIE Milestone series 102, 129 (1995). 
9. Laidevant, A. et al. Fluorescence time-resolved imaging system embedded in an 
ultrasound prostate probe. Biomedical optics express 2, 194–206 (2010). 
10. Passler, K., Nuster, R., Gratt, S., Burgholzer, P. & Paltauf, G. Piezoelectric 
annular array for large depth of field photoacoustic imaging. European 
Conferences on Biomedical Optics 2, 809012–809012–7 (2011). 
11. Petrovic, A. M., Siebert, J. E. & Rieke, P. E. Soil Bulk Density Analysis in Three 
Dimensions by Computed Tomographic Scanning1. Soil Science Society of 
America Journal 46, 445 (1982). 
12. Agarwal, A. et al. Targeted gold nanorod contrast agent for prostate cancer 
detection by photoacoustic imaging. Journal of Applied Physics 102, 064701 
(2007). 
13. Ku, G. & Wang, L. V. Deeply penetrating photoacoustic tomography in 
biological tissues enhanced with an optical contrast agent. Optics Letters 30, 507 
(2005). 
84 
 
14. Andreev, V. G., Karabutov, A. A. & Oraevsky, A. A. Detection of ultrawide-band 
ultrasound pulses in optoacoustic tomography. IEEE Transactions on 
Ultrasonics, Ferroelectrics and Frequency Control 50, 1383–1390 (2003). 
15. Nicholson, R. & Crofton, M. Training phantom for ultrasound guided biopsy. 
British Journal of Radiology 70, 192–194 (1997). 
16. Kato, H. An agar phantom for hyperthermia. Medical Physics 13, 396 (1986). 
17. Hebden, J. C., Price, B. D., Gibson, A. P. & Royle, G. A soft deformable tissue-
equivalent phantom for diffuse optical tomography. Physics in medicine and 
biology 51, 5581–90 (2006). 
18. Hebden, J. C., Hall, D. J., Firbank, M. & Delpy, D. T. Time-resolved optical 
imaging of a solid tissue-equivalent phantom. Applied optics 34, 8038–47 (1995). 
19. Pogue, B. & Patterson, M. Review of tissue simulating phantoms for optical 
spectroscopy, imaging and dosimetry. Journal of Biomedical Optics 11, (2006). 
20. Chen, E. J., Novakofski, J., Jenkins, W. K. & O‟Brien, W. D. Young‟s modulus 
measurements of soft tissues with application to elasticity imaging. IEEE 
Transactions on Ultrasonics, Ferroelectrics and Frequency Control 43, 191–194 
(1996). 
21. Foschum, F. & Kienle, A. Broadband absorption spectroscopy of turbid media by 
using a dual step steady-state method. Journal of biomedical optics 17, 037009 
(2012). 
22. Beard, P. C. Photoacoustic imaging of blood vessel equivalent phantoms. 
International Symposium on Biomedical Optics 54–62 
(2002).doi:10.1117/12.469848 
23. Cook, J. R., Bouchard, R. R. & Emelianov, S. Y. Tissue-mimicking phantoms for 
photoacoustic and ultrasonic imaging. Biomedical optics express 2, 3193–206 
(2011). 
24. Passler, K., Nuster, R., Gratt, S., Burgholzer, P. & Paltauf, G. Annular 
piezoelectric ring array for photoacoustic imaging. European Conferences on 
Biomedical Optics 809012–809012–7 (2011). 
25. Song, K. H. & Wang, L. V Deep reflection-mode photoacoustic imaging of 
biological tissue. Journal of Biomedical Optics 12, 60503 (2007). 
26. Esenaliev, R. O., Karabutov, A. A. & Oraevsky, A. A. Sensitivity of laser opto-
acoustic imaging in detection of small deeply embedded tumors. IEEE Journal of 
Selected Topics in Quantum Electronics 5, 981 (1999). 
85 
 
27. American National Standard for the safe use of lasers / secretariat, the Laser 
Institute of America. (Orlando, FL : The Institute, c1993: 1993). 
28. Thermo Scientific Spectronic 20+ and 20D+ Visible Spectrophotometers - Fisher 
Scientific. at 
<http://www.fishersci.com/ecomm/servlet/fsproductdetail_10652_5391897__-
1_0> 
29. Coefficient of Determination (R-Squared) - MATLAB & Simulink. at 
<http://www.mathworks.com/help/stats/coefficient-of-determination-r-
squared.html> 
30. Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 567 
(Psychology Press: 1988). 
31. Madsen, S. J., Patterson, M. S. & Wilson, B. C. The use of India ink as an optical 
absorber in tissue-simulating phantoms. Physics in Medicine and Biology 37, 
985–993 (1992). 
32. Ayache, N. Delingette, H. Golland, P. Mori, K. Medical Image Computing and 
Computer-Assisted Intervention. 1935, (Springer Berlin Heidelberg: Berlin, 
Heidelberg, 2000). 
33. Pickering, J. W. et al. Double-integrating-sphere system for measuring the optical 
properties of tissue. Applied optics 32, 399–410 (1993). 
34. Castelino, R. Biomedical applications of photoacoustics for thermal therapy . 72 
(2008). 
35. Prahl, S. A., van Gemert, M. J. & Welch, A. J. Determining the optical properties 
of turbid mediaby using the adding-doubling method. Applied optics 32, 559–68 
(1993). 
36. Roggan, A., Albrecht, H. J., Doerschel, K., Minet, O. & Mueller, G. J. 
Experimental set-up and Monte-Carlo model for the determination of optical 
tissue properties in the wavelength range 330 to 1100 nm. International 
Symposium on Biomedical Optics Europe  ’94 21–36 (1995). 
37. Yaroslavsky, I. V. & Tuchin, V. V. Inverse Monte Carlo method for 
spectrophotometric data processing. Volga Laser Tour  ’93 57–68 
(1994).doi:10.1117/12.179027 
38. Laufer, J. et al. In vivo longitudinal photoacoustic imaging of subcutaneous 
tumours in mice. Proceedings of SPIE 7899, 789915 (2011). 
86 
 
39. Michailovich, O. V & Tannenbaum, A. Despeckling of medical ultrasound 
images. IEEE transactions on ultrasonics, ferroelectrics, and frequency control 
53, 64–78 (2006). 
40. Laufer, J., Zhang, E., Raivich, G. & Beard, P. Three-dimensional noninvasive 
imaging of the vasculature in the mouse brain using a high resolution 
photoacoustic scanner. Applied Optics 48, D299–D306 (2009). 
41. Montilla, L. G., Olafsson, R., Bauer, D. R. & Witte, R. S. Real-time 
photoacoustic and ultrasound imaging: a simple solution for clinical ultrasound 
systems with linear arrays. Physics in medicine and biology 58, N1–12 (2013). 
42. Beard, P. Biomedical photoacoustic imaging. Interface focus 1, 602–31 (2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
 
 
CHAPTER 3 
 
OPTOACOUSTIC CHARACTERIZATION OF PROSTATE CANCER IN AN IN 
VIVO TRANSGENIC MURINE MODEL 
 
 
 
“Give me a place to stand, a lever long enough and a fulcrum and I can move the 
Earth”  
 
-Archimedes (287-212 BC.) 
picture from http://www.goodreads.com/author/show/661188.Archimedes 
 
 
 
 
 
 
 
 
The data presented in this chapter has been accepted for publication to Journal of 
Biomedical Optics (April 13  2014, manuscript #130660R).  
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Summary 
 Optoacoustic imaging was employed to distinguish normal from neoplastic tissues in a 
transgenic murine model of prostate cancer. Optoacoustic images of five tumour bearing 
mice and five age-matched controls across a 14 mm by 14 mm region of interest (ROI) 
on the lower abdomen were acquired using a reverse-mode optoacoustic imaging system 
(Seno Medical Instruments Inc., San Antonio, TX).   
Neoplastic prostate tissue was identified based on the optoacoustic signal amplitude in 
combination with spectral analysis of the optoacoustic radio frequency (RF) data.  
Integration of the signal amplitude images was performed to construct two-dimensional 
images of the region of interest (ROI).  The prostate tumours generated higher amplitude 
signals than those of the surrounding tissues, with contrast ratios ranging from 31 dB to 
36 dB.  The RF spectrum analysis showed significant differences between the tumour 
and control mice. The midband fit was higher by 5 dB (62%), the intercept higher by 4 
dB (57%) and the spectral slope higher by 0.4 dB/MHz (50%) for neoplastic prostate 
tissue compared to normal tissues in the control mice. The results demonstrate that 
optoacoustics offers high contrast imaging of prostate cancer in vivo.  
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3.1  Introduction 
 
 Conventional imaging techniques for prostate cancer such as ultrasound, 
computed tomography, and magnetic resonance imaging are used to identify abnormal 
areas in the prostate which may then be biopsied for a definitive diagnosis.  These 
imaging techniques do not reliably distinguish neoplastic from healthy prostate tissue 
1
, 
leading to the large sampling error associated with biopsies.  A sensitivity of only 50% 
is estimated for these techniques 
2
.  The ability to accurately visualize neoplastic regions 
in the prostate may improve biopsy targeting and reduce sampling error.   
 One of the most common techniques used for local evaluation of the prostate is 
transrectal ultrasound (TRUS) because it can be performed in real-time and has 
relatively good resolution 
3
.  TRUS often uses 5-7 MHz transducers, which provide 
resolutions of 0.3-0.5 mm at best 
3,4
.  However, the accuracy of this technique is 
reported to be less than 50-60% with respect to detection of prostate cancer, due largely 
to the weak contrast at depth in soft tissues 
5–7
.  Conventional diagnosis is currently 
based solely on the detection of gross anatomic properties of tissues 
6
.  Recent 
techniques have been developed that probe tissue microstructure based on the spectral 
analysis of radiofrequency (RF) data 
8,9
, however, these ultrasonic techniques do not 
provide any information on the oxygen saturation or hemoglobin concentration of the 
tissue, both of which are often altered with neoplasia 
10,11
.  Pure optical imaging 
techniques, such as diffuse optical tomography (DOT), are being investigated as 
possible targeting technologies for prostate cancer evaluation because of their ability to 
achieve adequate contrast in soft tissues,
 
and their ability to measure the oxygen 
saturation and hemoglobin concentrations of the tissues 
12,13
. These techniques suffer 
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from strong light scattering in biological tissues
 12
, resulting in either very limited 
imaging depth (<1 mm) as in optical coherence tomography (OCT), or limited 
resolution, as in DOT 
10
. 
This emerging technique of optoacoustic (OA) imaging overcomes the 
limitations described by merging the contrast capability of optical imaging with the 
resolution of ultrasound imaging 
13
.  The quality of contrast in OA imaging is related to 
the optical properties, as in pure optical imaging and the thermomechanical properties of 
the target while the resolution and the maximum imaging depth are scalable with the 
ultrasonic frequency as in ultrasound imaging 
10
.  Consequently, OA imaging can 
provide high contrast images with good resolution and penetration depth in soft tissue 
14,15
. 
 The OA technique exposes tissues to nanosecond pulsed laser light, which 
induces tissue-generated acoustic waves which are detected using wide band transducers 
14,15
.  The amplitude of an OA signal is largely dependent upon the optical absorption 
properties of the target tissues.  Solid tumours for example, often have an increased 
blood flow, and therefore hemoglobin concentration, compared to healthy tissue 
16,17
.  
The OA approach takes advantage of the high optical absorption of hemoglobin (oxy- 
and deoxy-) compared with other tissue parameters, at wavelengths in the visible and 
near infrared (NIR) range, to generate higher amplitude signals in regions with higher 
hemoglobin concentrations 
14,15.
 High resolution OA images of the mouse vasculature 
have been published by a number of groups 
18–22
. The frequency content of the 
generated OA sound waves is broadband and the detected signals are limited by the 
finite bandwidth of the ultrasound imaging transducers and the frequency dependent 
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attenuation of ultrasound in tissues 
23
.  The frequency content of the OA RF signals may 
reflect the anatomical properties of the absorbing structures in a manner similar to the 
established techniques involving spectral analysis of ultrasound RF data 
9,24,25
.  
Theoretical work has shown that frequency characteristics of OA signals can 
differentiate between normal and neoplastic tissues even when it is not possible to 
resolve individual blood vessels 
25
; an important consideration since many OA imaging 
systems cannot resolve individual blood vessels at the depth of the prostate in humans 
(approximately 10 cm 
26
) 
27,28
.   
Spectrum analysis of ultrasound RF data and its relation to tissue microstructure 
has been well described 
29
.  The size of the scattering structures compared to the 
wavelength of the incident ultrasound modifies the frequency content of the 
backscattered signal 
30
. Therefore, the frequency analysis of the ultrasound backscatter 
RF signals holds useful information about the medium sub-resolution structures.  Large 
databases have been developed, which are used with statistical classifiers to identify 
specific tissue types from spectral image data 
8
.  Analysis of the frequency parameters of 
the RF signals improves the diagnostic capabilities of conventional ultrasound imaging 
8,29,31
.   
Radio frequency data are collected in OA imaging wherein the size of the 
absorbing structure contributes to the frequency content of the OA signal 
32
.  Spectrum 
analysis of RF OA  signals generated by blood vessel phantoms (cylindrical tubes filled 
with ink and embedded into gelatin) show a relationship between the  spectral 
parameters and the diameter of the cylinders 
33
.  Spectrum analysis of high-frequency 
OA signals from ex vivo ocular tissue has also shown changes in the midband fit and 
92 
 
slope around the pigmented iris 
34
.  Thus, the relationship between the spectral 
parameters of OA data is likely linked to the physical properties of the target and more 
specifically the spatial distribution of the hemoglobin concentration within the tissues 
34
.   
Hence, quantitative measurements may allow for databases to be established for 
optoacoustics which, along with statistical classifiers, may be used to identify tissue 
types from amplitude images and RF analysis 
25
.  It may also offer additional 
information on the target physiology and vascular morphology.   
In this work, we utilized a low resolution, high contrast reverse-mode 
optoacoustic imaging system. Optoacoustic amplitude and frequency data were obtained 
from transgenic mice that develop prostate adenocarcinoma and age-matched controls. 
We posit that the analysis of the optoacoustic frequency parameters arising from non-
resolvable tissue structures can be used to distinguish normal from neoplastic tissues. 
3.2  Materials and Methods 
 3.2.1  Animal model 
            The transgenic adenocarcinoma of mouse prostate (TRAMP) model develops 
tumours similar to those reported in the human clinical prostate disease 
35,36
.  TRAMP 
mice develop spontaneous autochthonous prostate cancer with distant site metastasis
 36
.  
The tumour development begins as androgen-dependent growth and then progresses to 
androgen-independent, a progression similar to that of the human disease 
37
.  The 
tumours originate and develop within the prostate gland which means that unlike many 
other implanted tumour models, they cannot be palpated or visualized in the animal 
prior to imaging (unless evaluated in their late stages).  At the tissue level, the TRAMP 
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model also displays prostatic intraepithelial neoplasia (PIN) prior to adenocarcinoma 
formation 
35
.  TRAMP mice form prostate tumours as early as 12 weeks of age, with 
metastasis occurring as early as 24 weeks of age 
38
.  In the present study, we used five 
TRAMP mice and five age matched controls (C57BL/6J (wild type)) (Jackson 
Laboratories Inc, Maine, USA).   
 3.2.2  Optoacoustic Image Acquisition 
All procedures performed in this study were approved by the Animal Care 
Committee of the University of Prince Edward Island in accordance with the guidelines 
of the Canadian Council for Animal Care.  Imaging took place between 24 and 28 weeks 
of age.  Prior to imaging, each animal was placed in an anesthetic induction chamber 
and anesthetized with 2.5% isoflurane in 100% oxygen. Once anesthetized, the hair on 
the lower abdomen of the animal was removed using a chemical hair remover (Nair ®, 
Church & Dwight Corporation Inc., ON, Canada) and the area to be imaged (14 mm by 
14 mm) was marked using a permanent marker.  The animal was maintained under 
general anesthesia (2.5% isoflurane in 100% oxygen), secured to a vertical holder, and 
lowered up to the neck in a waterbath which contained the laser fibers and transducer. 
Imaging in water is required to optimize acoustic coupling.   
The imaging system (Seno Medical Instruments Inc., San Antonio, TX) consists 
of an Nd:YAG pumped Ti:Sapphire laser operating at 775 nm and an 8 element 
concentric annular array piezo-electric transducer (Chapter 2; Figure 2.1).  The piezo-
electric detection system consisting of 8 elements offers dynamic focusing capabilities 
which leads to a reduction in image artifacts compared to spherical detectors, and was 
selected because it allows for structures lying on the axis within a wide depth range to 
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be localized 
39,40
.     
The transducer has a nominal central frequency of 5 MHz, with a -6dB 
bandwidth of 60%, a focal point at 25 mm, a focal length of 10 mm, and a focal width of 
0.5 mm.  The bifurcated optical fiber bundle delivered 6 ns pulses at a 10 Hz repetition 
rate and 20 mJ of energy per pulse.  This is below the maximum permissible exposure 
limit of 100 mJ/cm
2
 at 775 nm as per the American National Standards Institute (ANSI) 
41
.  Throughout the imaging process, the mouse was held stationary as the fiber bundles 
and transducer array performed a raster scan across the selected area, moving in 0.2 mm 
steps and acquiring 4 OA signals at each position for averaging.  The OA data was 
acquired from a 14 mm by 14 mm region of interest (ROI_scan) at the lower abdomen 
of the mice that included the prostate region.  The ROI_scan was defined by the 
previously described marked outline drawn on the mouse.  The total imaging time was 
approximately 1.4 hours.  This imaging time is a result of the raster approach which, for 
our system, requires one second acquisition time at each step (including averaging) and 
there are approximately 4900 steps for each image.  
 Immediately following the image acquisition, each mouse was euthanized with 
intracardiac injection of sodium pentobarbital (65 mg/kg).  Three TRAMP and age-
matched control mice pairs were flash frozen in liquid nitrogen, in an upright position 
on the holder at all times to reduce organ migration.  The lower abdomen was dissected 
and 100 micron lateral cryosections were acquired for gross anatomical comparison with 
the OA images using a cryostat.  The other two TRAMP and age-matched control pairs 
were immediately dissected following euthanasia.  The prostate, seminal vesicles and 
any suspected abnormal tissues were fixed in a standard biological nitrogen fixation 
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(BNF) solution for histological processing.  The tissue was sectioned and examined for 
evidence of prostate adenocarcinoma.  The ROI_scan that was marked using a 
permanent marker prior to imaging was used to align the OA images with the 
cryosection photographs and histological sections. 
 3.2.3  Signal amplitude analysis 
 For the signal amplitude analysis, OA data from a 3 µs time window was 
extracted from each RF line. This time window corresponded to a 5 mm depth, 
beginning 1 mm beneath the front surface of the animal (and at the same depth in the 
age-matched control).  This removed the typically strong signals acquired from the 
animal skin surface and included data from tissue regions that included the prostate.  
The Hilbert transform was applied to all RF data 
27,42
.  The signal strength is presented 
as arbitrary units and all data were collected with the same constant gain settings.   
In order to account for optical attenuation by tissues which reduces the light 
available at depth for OA wave generation, we have employed a depth-dependent signal 
correction to each A-line. This is somewhat analogous to the use of time gain controls 
(TGC) in ultrasound imaging to account for acoustic attenuation, However, optical 
attenuation is significantly greater than the acoustic attenuation below 10 MHz in tissues 
27
.  The large aperture fiber bundles produce uncollimated light beams incident on the 
tissue surface. Hence, the subsurface fluence, I (z), at depth z is diffuse and, as such, can 
be described using the effective attenuation coefficient, μeff , according to Cox et al. 
43
,   
             
                  [1] 
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where μeff is the effective attenuation coefficient and z is the depth.  An effective optical 
attenuation coefficient of 3.1 cm
-1
 was used as reported for rat prostate tumours 
44
.  The 
final form of the correction factor was 
                                  
                       [2]
 A MATLAB® (The MathWorks Inc.) based script was developed and used to 
apply the attenuation estimate to the signals.   Such a correction was considered important 
given the variation in tumour depths that can occur among the TRAMP mice cohort.   
The signal within each 3 µs time window was integrated and projected onto a 
two-dimensional plane to form an image. A 2 mm by 2 mm region of interest was used 
for analysis (ROI_analysis).  This region size was chosen so that the ROI_analysis, if 
placed in the center of the smallest tumour, would be on-tumour tissue despite an 
estimated alignment uncertainty of 2 mm between the OA images and the 
cryosections/histological images.  The alignment uncertainty includes approximately 0.5 
mm uncertainty due to measured uncertainty of the positioning camera, as well as an 
estimated 1.5 mm uncertainty due to potential organ migration during image acquisition 
and prior to freezing.   
Contrast values were determined between on-tumour and adjacent (off-tumour) 
tissues within the OA image of the TRAMP mice, as well as between tumour and the 
normal prostate region of the age-matched control.  Contrast was measured by 
subtracting the average signal value within the ROI_analysis on control tissue from the 
average signal value within the ROI_analysis on tumour tissue and dividing by the 
standard deviation  
45,46
.    
97 
 
The tumour boundary was determined using the full width half maximum 
(FWHM) of the signal in the two-dimensional image.  Hence, regions with signals 
greater than half the maximum signal were defined as 'on-tumour' 
22
. 
3.2.4  Frequency Spectrum Analysis 
A spectrum analysis technique commonly performed on ultrasonic backscatter 
RF data was used for this analysis 
29
.  To obtain the sensitivity of the transducer at 
different frequencies, a calibrated power spectrum was obtained by using a 200 nm thick 
gold film.  The film was deposited onto a thin microscope cover slide with no annealing.  
The gold film was used because it has a broad OA power spectrum as well as a flat 
response in the known bandwidth of the transducer thus providing a good measure of the 
transducer response  
47
.  OA measurements were obtained across an area of 
approximately 1 cm
2
 at 775 nm using the same power settings as the OA measurements 
of the TRAMP mice.  A total of 20 OA signals were recorded.  This was referred to as 
the calibrated power spectrum.  
The fast fourier transform (FFT) was applied to the tissue RF data to calculate 
the RF echo spectrum.  The mean of the squared spectral magnitudes is the averaged 
power spectrum (APS).  The APS was converted into the decibel (dB) scale.  A 
calibrated power spectrum is subtracted from the converted APS to remove any system-
specific artifacts caused by the transducer characteristics at the focus, and system 
electronics.    
Values were calculated over a 5 mm depth beginning 1 mm before the front 
surface of the tumour.  The same 4 mm by 4 mm ROI_analysis used for the contrast 
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measurements was used.  Values were calculated at each position (i.e. every 0.2 mm) 
within the 4 mm by 4 mm ROI_analysis and averaged.  The same acquisition plane was 
used on the TRAMP mice and age-matched controls.   
A sliding Hamming window was employed which has been shown to 
significantly reduce noise in spectrum analysis of ultrasound data 
29
.  The Hamming 
window had a width of 1 mm and moved in 0.5 mm steps along the axial direction.  A 1 
mm window was chosen so that approximately three acoustic wavelengths (at the central 
frequency of the transducer) were contained within each window.   The power spectrum 
at each location was the average of the measured spectrum in each hamming window.  
 A linear regression was performed on the averaged power spectrum between 1 
and 6 MHz  and the midband fit, slope, and intercept extracted from the fit.  This region 
was chosen based on the approximate linearity of the dataset and the high signal to noise 
(SNR of 5.3 dB) within these frequencies. The statistical spread of these parameters for 
ultrasound RF data has been previously established by others 
29
.    
The normality of the spectral data was confirmed using a Shapiro-Wilk test with 
W>0.05 used as the criterion for normality.  The variances of the spectral parameters 
(on versus off tumour) were found to be equal using an F-test with F<0.05 used as the 
criterion for equal variance.  A paired t-test was used to compare the spectral parameters 
between normal and neoplastic tissue.  A p-value of 0.05 or less was used to define 
statistically significant differences.   
 3.3  Results  
 3.3.1  Optoacoustic Imaging  
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 Representative TRAMP and age-matched control cryosection and integrated OA 
signal amplitude images are shown in Figure 3.1.  Approximate areas imaged on the 
animals are represented by black outlines.  The cryosection images of both sets of 
control and TRAMP mice were taken from the same depth beneath the surface of the 
animal, 6.0 ± 0.1 mm and 7.9 ± 0.1 mm respectively, which corresponds to the 
maximum coronal tumour dimension in the TRAMP mice (determined from the 
cryosections).  Each TRAMP image was normalized to its maximum signal value, and 
each control image was normalized to the maximum signal value from the image of its 
age-matched TRAMP.  The OA image of the TRAMP mouse in Figure 3.1(b) shows an 
increase in signal amplitude in the region of the tumour and relatively sharp decreases in 
signal at the border of the tumour.  The signals obtained from the control mouse are 
typically less than 0.5 a.u. and therefore beneath our defined threshold of tumour tissue 
(as defined in material and methods using the FWHM, and therefore above 0.5 a.u.).   
The tumour of the second TRAMP mouse was less vascular compared to that of the first 
TRAMP mouse and has therefore been outlined in Figure 3.1(e) for easier visualization. 
Again the tumour is visible in the corresponding OA image, Figure 3.1(f), and the OA 
predicted vertical and horizontals dimensions are 7.0 ± 0.5 mm and 6.0 ± 0.5  mm which 
agree reasonably with actual dimensions. OA contrast for tumour compared to adjacent 
normal, healthy tissue ranged from 31-36 dB across the 5 TRAMP mice (Table 3.1). OA 
contrast for tumour compared to the region of the prostate on the age-matched control 
animal, also ranged from 31-36 dB. The uncertainties of the contrast values are one 
standard deviation of the values measured within the boundaries of the ROI_analysis in 
the OA image.   
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Figure 3.1: Coronal cryosection images of TRAMP tumor bearing mice (a, e), and age 
matched control mice (c, g).  Approximate areas imaged on animals are represented by 
black outlines.  Corresponding coronal integrated signal amplitude images of tumor 
bearing TRAMP mice (b and f) and age matched control mice (d and h).  Both sets of 
optoacoustic images (TRAMP and age-matched control) were normalized to the 
maximum signal value of the TRAMP image  
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Table 3.1 Optoacoustic image contrast for 5 TRAMP mice and age-matched controls, 
and lateral TRAMP tumour dimensions.  Values are presented as mean ± standard 
deviation.  
Animal# Contrast (dB) Lateral Dimension (mm) 
 Tumour - 
Adjacent 
Tumour - 
Control 
From OA 
Image ± 0.4 
From 
Cryosection ± 
0.5 
1 33 ± 2 34± 2 8.8 9.0 
2 31 ± 2 35± 2 7.0 7.0 
3 33 ± 2 36± 2 6.0 6.5 
4 36 ± 2 34± 2 5.6 6.0 
5 31 ± 2 31± 2 8.0 8.0 
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 The OA predicted maximum lateral tumour dimension, determined using the 
FWHM approach, and the dimensions determined from the cryosections for the five 
TRAMP mice are summarized in Table 3.1. The mean tumour dimensions and 
measurement error (measured on cryosections) ranged from 6.0 ± 0.5 mm to 9.0 ± 0.5 
mm.  The results show that the OA predicted tumour dimensions agreed with the  
cryosection tumour dimensions to within 0.5 mm in all 5 TRAMP mice. 
3.3.2  Frequency Spectrum Analysis 
Representative calibrated and non-calibrated power spectra for one OA data set 
are shown in Figure 3.2.  A linear fit was applied to the normalized spectrum between 1 
and 6 MHz.    
Midband fit, intercept and slope values for the 5 TRAMP mice and age-matched 
controls are presented in Figure 3.3 and Table 3.2.  Each value represents an average of 
100 spectral parameters acquired within a 2 mm by 2 mm square region of interest.  
Error bars represent one standard deviation.  Tumour tissues generated higher values of 
all three parameters compared with normal tissues (adjacent and control).  
Mean and standard deviation values from all TRAMP mice on tumour and on 
adjacent tissue, and from all control mice are presented in Table 3.2.  There was a six 
fold increase in midband fit and a two fold increase in slope values on tumour compared 
with control.  Significant differences (p<0.05) were found between all spectral 
parameters.  No significant difference was found between the control and adjacent 
spectral parameter values.   
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Figure 3.2: Representative power spectrums. a) uncalibrated radio frequency tissue 
spectrum and calibration spectrum of the 5 MHz transducer, b) The calibrated tissue 
power spectrum and linear fit applied between 1 and 6 MHz 
0 5 10
-60
-50
-40
-30
-20
Frequency (MHz)
A
m
p
li
tu
d
e
 (
d
B
)
 
 
Calibration spectrum
RF tissue spectrum
1 2 3 4 5 6
-4
-3
-2
-1
0
1
2
3
Frequency (MHz)
A
m
p
li
tu
d
e
 (
d
B
)
 
 
Calibrated spectrum
Linear fit
(a) (b)
104 
 
 
Figure 3.3:  Spectral parameters on tumor and adjacent to tumor for each TRAMP 
mouse and age-matched control mouse.  Each value represents an average of spectral 
parameters acquired within a 2 mm by 2 mm by 2 mm region of interest.  
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Table 3.2 Average and standard deviations of spectral parameters on tumour and 
adjacent to tumour for all TRAMP and for all control mice.  N=5. 
OA = optoacoustic 
 
 
 
 
 
Spectral 
Parameter 
Control Adjacent  Tumour 
t-test (p value) 
tumour/control  tumour/adjacent 
OA midband fit (dB) -5±1 -5±1 1±1 0.0114 0.0040 
OA slope (dB/MHz) 0.4±0.1 0.4±0.1 0.8±0.1 0.0026 <0.001 
OA intercept (dB) -7±2 -8±1 -3±1 0.0155 <0.001 
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A cross-sectional profile of the slope across the lateral dimension of a 
representative tumour is shown in Figure 3.4.  Slope values are independent of signal 
strength (provided the SNR is adequate) and would remove the need to correct for 
optical attenuation.  Therefore, analyzing slope values may be a more robust method of 
identifying tumour boundaries.  The image shows that there is a gradual increase in 
slope values from the boundaries of the tumour to the center and variation within. 
3.4  Discussion and Conclusions 
  
 The goal of this study was to demonstrate the potential of optoacoustic imaging 
to distinguish neoplastic prostate tissue in a transgenic tumour model from normal tissue 
in a control model. This potential was confirmed in so far as  amplitude and RF 
frequency parameters of the OA signals showed significant differences between 
cancerous and normal tissues.  The results may arise from the principle that the 
amplitude of the OA signal is largely affected by the optical absorption of the target  
(determined by e.g. blood vessel size, oxygenation status) while the frequency parameter 
may be more related to the geometrical properties of absorbing structures (e.g. blood 
vessel size, oxygenation status and spatial distribution) 
32
.   
 By integrating the OA signal within an ROI, two-dimensional OA images of the 
maximum tumour dimensions were generated and resulted in contrast values of 31 dB to 
36 dB.  The OA predicted dimensions agree with the true dimensions to within 0.5 mm. 
Further data from an increased number of animals may allow a more precise estimate of 
these variables to facilitate calibration of the OA data analysis. 
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Figure 3.4:  Representative slope (dB/MHz) values across the lateral direction through a 
tumor in the TRAMP model (red) and in the control animal (blue).  Vertical lines 
represent the boundaries of the tumor obtained from full width half max measurements 
on the OA amplitude images. 
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Theoretical models relating the spectral intercept and slope for conventional 
ultrasound RF data and the tissue scattering structures have been well established 
8,29
.  
For conventional ultrasound imaging, the spectral parameters, slope, intercept and 
midband fit are related to the physical characteristics of the target scatterer  (e.g. the 
size, shape, acoustic impedance and spatial distribution of the scatterering sources) 
8
.  
The primary absorbing target for optoacoustic application in this paper was hemoglobin, 
which is localized in blood vessels.   
The axial position of the front surface of the tumour in the OA image correlated 
to within 0.5 mm of the position measured during cryosectioning.  The two-dimensional 
raster scan method of acquiring OA signals results in limited axial penetration depth due 
to the large optical attenuation in tissue (especially in tumour tissues due to elevated 
hemoglobin concentration) 
44
.  To account for this optical attenuation, a depth dependent 
signal correction factor was applied to the OA signals prior to analysis.   
The amplitude of the OA signal strongly affects the amplitude of the frequency 
spectrum, thereby affecting the midband fit and intercept values while the slope should 
be independent of amplitude (provided the signal to noise is adequate) 
48
.  The OA 
signal amplitude is depth dependent due to high optical attenuation in tissues.  For 
example, tumours with similar optoacoustic characteristics but positioned at different 
depths may yield different midband and intercept values.  Hence, correcting for changes 
in fluence for variable target (ie. tumour) depths is important. The depth dependent 
signal correction applied to the OA signals in this study represents an initial approach 
towards accounting for the optical attenuation.  Significant differences between spectral 
parameters were found with and without the correction factor (data not shown). 
109 
 
 Differences in spectral parameters of neoplastic tissue compared with healthy 
tissue have  been reported for ultrasound RF data 
49
.  Neoplastic tissues have different 
microstructure than that of healthy tissue, for example, neoplastic tissues are often 
denser than normal tissue and consist of more tortuous vasculature 
50
.  This leads to 
significant differences in the spectral parameters associated with neoplastic tissue 
compared to many healthy tissues 
51
.  Use the methods described in this chapter, the 
authors were also able to differentiate between control and neoplastic prostate tissue.  
A similar spectrum analysis technique for optoacoustics has been reported by 
Kumon et al. (2011) who found a significant increase in the midband fit between on and 
off tumour but no significant differences for the intercept and slope 
52
.  Kumon et al. 
(2011) found midband fit values were 8.8 dB higher on tumour compared with adjacent 
normal tissue.  Similarily, we found midband fit values were 6 dB higher on tumour 
compared with adjacent tissue.  The slope values presented by Kumon et al. (2001) were 
0.5 dB/MHz higher on tumour (with no significant difference between tumour and 
normal) compared with the slope values of this study which were 0.4 dB/MHz higher on 
tumour tissue and significantly different from normal tissue.  Our study demonstrates 
significant differences in all three spectral parameters between on and off tumour.  
Furthermore, control animals were used in this study to ensure that the OA signals 
adjacent to the tumour were consistent with normal tissues, and not affected by the 
presence of the tumour.  
A two-dimensional image of the slope values across a representative tumour 
show that there is a gradual increase in the values across the boundaries of the tumour.  
Slope values are independent of signal strength (provided the SNR is adequate) and 
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would remove the need to correct for optical attenuation.  Therefore, analyzing slope 
values may be a more robust method of identifying tumour boundaries. 
OA imaging has shown promising initial results for detecting the presence of 
cancerous tumours with high contrast and good resolution compared with conventional 
ultrasound imaging 
10,14,15
.   Based upon the findings in the current study, using 
frequency spectrum analysis in combination with the current amplitude presentation of 
OA images may offer potentially important information about the tumour (e.g. vascular 
density, diameter, etc.).  In terms of applying these findings in a clinical setting, OA 
imaging (amplitude presentation) may be used to detect the presence of a tumour and its 
position in the tissue/organ.  Frequency analysis of the RF signals from this tumour 
could then be performed to obtain further information on its physiological properties 
which may be indicative of its aggressiveness and treatability.  Typical qualitative OA 
images, using only signal amplitude information, are also subject to a variety of user- 
and system-dependent factors (e.g. brightness/contrast, thresholding, laser fluence, etc.) 
that make it difficult to compare between studies 
52,53
.  Frequency analysis described 
herein removes many of these factors by compensating for the system response and 
correcting for loss in optical fluence with depth.   
It is acknowledged that the effective acquisition time of this system (~ 1 Hz) is 
slow for clinical application, and is due to the limitation‟s of the existing firmware. 
Future work will involve decreasing this delay time to optimize imaging time while 
minimizing any detection of signal generated by previous pulses. 
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 Additional studies including a larger number of animals are required to further 
validate the contrast between tumour, the pre-neoplastic tissue, and healthy prostate as 
presented in this paper, and to determine the optimal analysis techniques for image 
generation and boundary determination.  A framework for understanding how spectral 
features are related to tissue physiology will need to be established along with statistical 
methods for classifying different tissues 
29
.  Optoacoustic imaging of prostate tumours 
obtained at varying time points may also demonstrate the capability of these analysis 
techniques to not only detect the presence of the tumor but to also give an indication of 
the extent of the disease.   
In summary, this study reports that there are significant differences between the 
amplitude and frequency content of OA signals between tumour and healthy tissue.    
The increased signal amplitude was attributed to the increased vascularization within the 
tumour.  The differences in the frequency parameters however are likely due to the 
combination of increased vascularization and vascular heterogeneity (more tortuous and 
smaller vessels size) of tumour tissues compared to healthy tissues. Frequency analysis, 
unlike amplitude analysis, of optoacoustic signals provides information about non-
resolvable vascular structures, an important consideration since many optoacoustic 
imaging systems cannot resolve individual blood vessels at the depth of the prostate 
27,28
.  
Knowledge of these vascular characteristics may aid in cancer diagnosis and treatment 
planning.  This report has demonstrated the utility of standard pulse-echo spectrum 
analysis techniques for optoacoustic characterization of normal and neoplastic tissues. 
The results of this work contribute to the growing evidence-based support for 
optoacoustics as a cancer imaging tool.    
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CHAPTER 4 
OPTOACOUSTIC SIGNAL AMPLITUDE AND FREQUENCY SPECTRUM 
ANALYSIS OF LASER HEATED BOVINE LIVER EX VIVO 
 
 
 
“There are only two ways to live your life. One is as though nothing is a miracle. The 
other is as though everything is a miracle.” 
-Albert Einstein (1879-1955) 
picture from http://www.goodreads.com/author/show/9810.Albert_Einstein 
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Summary 
Frequency analysis of optoacoustic (OA) signals has been investigated for the direct 
detection of tissue thermal damage for the purpose of monitoring laser thermal therapy 
(LTT).  Spectrum analysis is commonly performed on ultrasound backscatter radio 
frequency (RF) data, which calculates the spectral midband fit, slope, and the intercept 
of the data, and was used to quantify the frequency changes in the OA RF signal. The 
potential to monitor tissue damage directly and in real-time, using OA imaging is 
desirable, rather than through a surrogate of temperature.  OA images were acquired 
from ex vivo bovine liver using a reverse-mode OA imaging system consisting of a 
pulsed laser operating at 775 nm and an 8 element annular array ultrasound transducer.  
LTT was performed with an 810 nm laser at 4 W for 5 minutes.  OA signals were 
acquired for 2 minutes prior to, 5 minutes during, and 7 minutes post treatment at a rate 
of 2 Hz. Heat induced effects were identified based on the OA signal amplitude in 
combination with spectral analysis of the OA radio frequency (RF) data.  
In agreement with previous work, the OA signal amplitude was strongly affected by the 
temperature of the target and increased continuously as the heat was applied.  The 
spectral midband fit and intercept increased to a maximum within three minutes of 
heating then remained at this maximum for the duration of the experiment (even as the 
temperature of the sample decreased).   The spectral slope decreased to a minimum 
within two minutes of heating and remained at this value for the duration of the 
experiment.   
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The midband fit and intercept increased on average by 7 dB and 9 dB respectively, and 
the slope decreased on average by 0.3 dB.  The amplitude of the OA signals post-
treatment was on average three times higher compared with pre-treatment signals.  
The results of this study demonstrate that analysis of OA frequency components may 
prove to be a more direct measure of tissue damage, than temperature.  Such OA 
frequency analysis in combination with OA thermometry may prove to be an improved 
strategy for monitoring laser thermal therapy.    
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4.1  Introduction 
Laser Thermal Therapy (LTT) is a minimally invasive technique for destroying 
diseased tissue.  The feasibility of LTT as a tool for selective tissue destruction has been 
demonstrated in a number of sites including the breast 
1
, brain 
2,3
, liver 
4,5
 and prostate 
6,7
.  Thermal therapy involves heating tissue to between 55 and 90
o
C for several minutes 
resulting in cell death 
8
.  Cell death occurs when thermal damage results in irreversible 
denaturation of proteins (i.e. coagulation), typically at temperatures above 55
o
C.  
Contrary to other approaches such as hyperthermia (heating tissues between 41-45
o
C),  
thermal therapy may act as a stand-alone therapy.  
Heating tissues to induce cellular death results in highly variable outcomes 
which can result in insufficient (leading to recurrence) or overly aggressive treatment 
(morbidity of surrounding healthy tissues) 
9
.  These risks necessitate precise and 
continuous monitoring during treatment 
10
.  For prostate treatments, real-time 
monitoring offers the possibility of ensuring that the entire tumour has been destroyed 
while peri-prostatic critical structures are spared.   
Several non-invasive techniques have been used for monitoring tissue 
temperatures during LTT including point sensors (e.g. thermocouples, fluoroptic probes) 
11
, magnetic resonance imaging (MRI) 
12,13
, ultrasound imaging 
14,15
 and photoacoustic 
(i.e. optoacoustic) imaging
16,17
.  Point sensors provide temperature information at 
specific locations, hence offer only a limited data set for monitoring.  Furthermore, 
temperature monitoring using point sensors has proven to be inadequate due to the time 
delay in the conduction of thermal energy from the heating source to the temperature 
probe 
8
.  This may result in temperatures exceeding safe limits close to the heating 
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source before they are detected by the temperature probes resulting in undesirable tissue 
charring 
18
. 
MRI thermometry provides real-time, three-dimensional maps of tissue 
temperature 
2
.  Unfortunately, significant image artifacts often arise from patient 
movement, which necessitates constant recalibration 
19
.  This type of monitoring is also 
generally cost-prohibitive for most treatment centers 
20
.   
Ultrasound monitoring provides real-time imaging, and is relatively cost 
effective.  However it suffers from low contrast for coagulation monitoring, because the 
speed of sound in coagulated tissue is similar to that of native tissue 
21,22
.   MRI 
thermometry is also expensive and logistically challenging for temperature 
measurements in a clinical setting due to need for repeated calibrations due to patient 
movement  
23,24
.     
Optoacoustic (OA) imaging exposes tissues to nanosecond pulsed laser light, 
which induces tissue generated acoustic waves which can be detected using wide band 
transducers 
25,26
.  OA imaging can provide three-dimensional information in real-time 
with high contrast and deep penetration depth 
27,28
.  The amplitude of an OA signal is 
dependent upon the Grüneisen parameter, which increases with temperature.  The 
amplitude is also dependent on the optical absorption properties of the target tissues, and 
therefore provides the opportunity to take advantage of the significant changes in tissue 
optical properties, at wavelengths in the visible and near infrared (NIR) range, due to 
thermal coagulation 
11
.   
The frequency content of the generated OA sound waves is broadband, but the 
detected signals are limited by the finite bandwidth of the ultrasound imaging 
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transducers (detection range) and the frequency dependent attenuation of ultrasound in 
tissues 
29
.  The frequency components of the signals may depend on anatomical 
properties of the absorbing structures in a manner somewhat similar to conventional 
ultrasound imaging 
30–32
.   
In this work, we hypothesize that the physical changes which occur in the tissue 
during coagulation, such as the constriction of blood vessels, increased optical 
scattering, changes to the Grűneisen parameter, and protein unfolding 33, may influence 
the frequency content of the OA wave generation and be detected using spectrum 
analyzing techniques commonly performed on ultrasonic backscatter RF data 
34
.   
4.2  Materials and Methods 
4.2.1 Imaging protocol 
Sixteen randomly selected liver samples obtained from 8 different bovine livers 
(purchased from a local butcher) were cut to approximately 2 cm by 2 cm with 1 cm 
thickness and vacuum sealed inside a clear plastic bag (Figure 4.1).  Bovine liver was 
chosen because its optical properties (µa ≈ 3 cm
-1
 and µs ≈ 5 cm
-1
 at 775 nm) have been 
reported to be representative of a highly vascularized tumour (µa ≥ 2 cm
-1
 and µs ≥ 5 cm
-
1
 at 775 nm) 
35
.  
Each liver sample was secured inside the waterbath (held at 38 °C) of a reverse-
mode optoacoustic imaging system (Seno Medical Instruments Inc., San Antonio, TX) 
(Figure 4.2). The system consisted of an Nd:YAG pumped Ti:Sapphire laser operating 
at 775 nm and an 8 element annular array piezo-electric transducer with a nominal 
central frequency of 5 MHz (-6dB bandwidth of 60%). A bifurcated optical fiber bundle 
delivered 6 ns pulses at a 10 Hz repetition rate and 12 mJ of energy per pulse, for a  
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Figure 4.1:   A representative bovine liver sample cut to approximately 2 cm by 2 cm 
by 1 cm thickness post-heating.  Each sample was sealed inside a clear plastic bag and 
secured to a holder during the image acquisition.  Lines were drawn on the plastic bag, 
using a metallic permanent marker, forming a box of 3 mm by 3 mm for easier 
positioning. 
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Figure 4.2:  Photograph and schematic of the Imagio small animal optoacoustic 
imaging system setup.  Laser optical path intercepts at 25 mm from the transducer which 
is located beneath a camera used for image positioning. The sample remained stationary 
as optoacoustic signals were acquired at one point over 14 minutes including 2 minutes 
prior to heating, 5 minutes during 4W laser heating and 7 minutes post heating 
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surface irradiance of 0.19 W/cm
2
.  The bifurcated fiber bundle and transducer array 
were positioned 2 cm from the surface of the liver sample 
An 810 nm laser (BWF2, BWTEK, Inc) with a maximum power output of 15 W 
was used to deliver the thermal therapy.  The laser fiber was positioned in the water bath 
approximately 2 cm from the opposite side of the liver sample, along the same axis as 
the OA transducer array.  This resulted in an illuminated area on the samples surface of 
approximately 1 cm in diameter.   The liver irradiation was performed at 4 W for 5 
minutes. A calibrated fluoroptic temperature probe (Lumasense Technologies, CA) 
(icebath calibrated) was placed along the same axis as the center of the 810 nm laser 
beam and OA transducer on the surface of the sample facing the 810 nm laser to 
measure the surface temperature of the sample. Once aligned, the transducer array 
position was fixed for the entire period of heating.  Prior to OA imaging the fluoroptic 
probe was used to ensure that the liver sample had equilibrated to 38
o
C (core body 
temperature of a murine animal). During laser heating, the temperature was measured 
every one second.    
A-lines (2 signals/second) were acquired along the axis of the 810 nm laser with 
no temporal averaging.  OA signals were acquired for 2 minutes prior to heating to 
obtain baseline data for the liver sample.  The tissue was then exposed to the 810 nm 
laser for 5 minutes while OA data was continuously acquired.  A 5 minute exposure 
duration was used which created 1 cm wide and 0.5 cm deep lesions at the heated 
surface of the sample.  The 810 nm laser was then turned off and OA signals were 
acquired for 7 minutes during which time the temperature of the liver sample decrease to 
below 43
o
C, as measured by the fluoroptic probe.  
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4.2.2 Data Analysis 
A MATLAB® (The MathWorks Inc., MA) based script was developed and used 
for the analysis of both amplitude and spectral components of the OA signals.  The 
Hilbert transform was applied to all RF data 
36–38
.   The OA signals from a time window 
that represents tissue from 27 mm and 32 mm from the transducer was used.  This 
window excluded the typically strong OA signals obtained from tissue surfaces
39
 and 
included all signals within the 0.5 cm  of  liver tissue that was thermally damaged.  An 
integration of each A-line between 27 mm and 32 mm was performed.  The average OA 
signal obtained prior to laser exposure was divided from all OA signals to remove the 
baseline signal originating from the untreated tissue.   
To obtain the sensitivity of the transducer at different frequencies, a calibrated 
power spectrum was obtained by using a 200 nm thick gold film.  The film was 
deposited onto a thin microscope cover slide with no annealing.  A gold film was used 
because it has a broad OA power spectrum as well as a flat response in the known 
bandwidth of the transducer, thus providing a measure of the transducer response  
40
.  
OA measurements at 775 nm were obtained across an area of approximately 1 cm by 1 
cm using the same power settings as were used for the liver samples.  A total of 20 OA 
signals were recorded.  These are referred to as the calibrated power spectra.  
For each signal, the FFT was applied to the tissue RF data to calculate the RF 
echo spectrum.  The mean of the squared spectral magnitudes is equivalent to the 
averaged power spectrum (APS).  The APS was converted into the decibel (dB) scale.  
A calibrated power spectrum was subtracted from the converted APS to remove any 
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system-specific artifacts caused by the transducer characteristics at the focus and system 
electronics.    
 Linear regression was performed on the averaged power spectrum between 1 and 
6 MHz and the midband fit, slope, and intercept extracted from the fit.  This frequency 
region was chosen based on the approximate linearity of the dataset and the high signal 
to noise (SNR of 3.7 dB) within these frequencies. The statistical spread of these 
parameters for ultrasound RF data has been previously established by others 
34
.    
A region of interest (ROI) of 5 mm by 5 mm by 5 mm centered on the lesion and 
on the treated side of the sample (the approximate depth in which all the samples were 
damaged) was chosen for analysis.   
During LTT, the clinical goal is to raise the tissue temperature to induce 
coagulated necrosis.  This thermal damage can be quantified using the concept of 
thermal dose 
41
.  Thermal dose was calculated using continuous tissue temperature data 
and as approximated by the cumulative equivalent minutes at 43°C, CEM43°C, model 
41–43
.      
                         
 
             (1) 
 
 
Where  R is 0.5 when T is greater than 43°C, and 0.25 when T is less than 43°C.  
T is the temperature during a change in time ∆ti.  
Surface temperatures, which were recorded every 1 second using a calibrated 
fluoroptic probe, were input into the CEM43°C equation to calculate the thermal dose. 
The normality of the spectral parameters was confirmed using a Shapiro-Wilk 
test with W>0.05 used as the criterion for normality 
44
.  The variances of the spectral 
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parameters were found to be equal using an F-test with F<0.05 used as the criterion for 
equal variance.  A paired t-test was used to compare the spectral parameters between 
normal and neoplastic tissue.  A p-value of 0.05 or less was used to define statistically 
significant differences.   
4.3 Results 
Each liver sample underwent the same laser treatment protocol which produced 
coagulated lesions approximately 1 ± 0.2 cm diameter (at the heated surface) and of 0.5 
± 0.1 cm depth.  Figure 4.3 shows a representative liver sample post-heating. 
 Figure 4.4 presents a boxplot of normalized OA signal amplitudes (Hilbert 
transformed) of 16 liver samples prior to, during and post heating near the surface, as 
well as the temperatures at the surface of the sample.  Figure 4.5 shows the average 
amplitude values of all 16 samples versus temperature. 
 Sample temperature prior to imaging was 38°C.  Maximum surface temperatures 
of 60-70
o
C were measured using the fluoroptic probe (an increase of 22-32°C).  The 
amplitude of the OA signal increased continuously with heading, and reached a 
maximum that is on average 9 ± 2 times higher than the pre-heating OA signal.  With 
the heat source removed, at 7 minutes, the OA signal decreased for approximately 4 
minutes and then leveled off at an amplitude 7 ± 2 times higher than the pre-heating OA  
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Figure  4.3: A representative bovine liver sample cut to approximately 2 cm by 2 cm by 
1 cm post-heating with a) ~1 cm of coagulation on the heated surface, and b) a 
coagulation depth of ~0.5 cm.   
 
 
 
 
 
a) b)
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Figure 4.4: Normalized integrated optoacoustic signal (a) and surface temperature 
measurements (b) versus time of the 16 repeated trials (N=16). The shaded red area 
represents the time during heating.  Boxplot represents mean, one standard deviation and 
spread of data.   
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signal.   The data presented in Figure 4.5 can also be separated into three different 
phases, 1) heating without coagulation, 2) heating with coagulation and 3) cooling. The 
amplitude increased slowly up to the temperature of approximately 53°C, with a slope 
of 0.008.  The sharp increase in the amplitude was detected at temperatures above 53°C 
where the slope increases to 0.05.  This steep increase was considered likely due to the 
rapid changes in optical scattering coefficient which occur during the coagulation 
process.  During the cooling of the tissue, the amplitude decreased slowly with a slope 
of 0.01, similar to that during heating without coagulation.  Variation was not included 
in the average data points presented in this figure for easier viewing.  Variation in the 
OA signal strength ranged from 0.05 to 0.2 a.u.  Spectral parameters were measured and 
averaged over one minute intervals and are presented in Figure 4.6.   
The midband fit and intercept values increased for approximately three minutes 
as the heat was applied to the sample and then leveled off at a maximum value of 7 ± 1 
dB and 8 ± 1 dB higher than pre-heating values respectively (unlike the OA amplitude 
which increased continuously during heating).  When the laser was turned off and the 
heat removed (at 7 minutes), the midband fit and intercept values remained at their 
maximum values (unlike amplitude values which decrease during cooling).  The slope 
values decreased to a minimum within two minutes of heating and remained at this 
value during and the post-heating phase.  The midband fit and intercept values increased 
until the temperature reached approximately 55°C and then leveled off.  The slope 
values increased until the temperature reached approximately 50°C.     
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 Figure 4.5:  Average optoacoustic signal amplitude versus temperature for the 16 
repeated heating experiments (N=16).  Signals was acquired 2 minutes prior to laser 
thermal therapy (LTT), 5 minutes during LTT and 7 minutes post LTT in bovine liver ex 
vivo.   
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Figure 4.6:  Spectral parameters a) midband fit, b) intercept and c) slope) recorded prior 
to, during and post laser thermal therapy performed on ex vivo bovine hepatic tissue.  
Shaded area represents the period of laser heating.  The shaded red region represents the 
time of heating.  Boxplot represents mean, one standard deviation and spread of data 
(N=16). 
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Figure 4.7 presents the average spectral parameter values of the 16 samples 
versus calculated CEM43°C.  Variation was not included in the average data points 
presented in this figure for easier viewing.  Variation in the OA signal strength ranged 
from 0.05 to 0.2 a.u.   
The mean and standard deviations that apply to the OA signal amplitude and 
each spectral component were calculated prior to heating (0-2 minutes), during heating 
(2-7 minutes) and post heating (7-14 minutes).   A Welch‟s t-test was applied to the data 
(α=0.05).  Significant differences were found between the amplitude and spectral 
components prior to and post-heating.  Significant differences were not found between 
any of the parameters during and post-heating.  Results are summarized in Table 4.1. 
Detectable changes were seen in the amplitude and all three spectral parameters 
prior to heating compared to during and post laser application.  The intercept and 
midband fit increased by 9 dB and 7 dB respectively and the slope decreased by 0.3 dB 
post-treatment compared to pre-treatment.  Post-treatment, as the tissue returned to its 
initial temperature, and there were no significant changes in the spectral components 
compared to those measured during treatment. 
4.4  Discussion and Conclusions 
The absolute OA amplitude is largely affected by the position of the transducer 
in relation to the sample 
16
.  Therefore, the OA signals from each sample were 
normalized to account for small discrepancies in the transducer placement.  
The amplitude of the OA signal is strongly affected by the temperature of the target 
21,45
. 
As shown in Figure 4.4, the OA signal increases continuously as heat is  
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 Figure 4.7: Spectral parameters versus calculated thermal dose at 43°C from the 
averaged temperature during heating of 16 repeated trials (N=16).  
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Table 4.1: Averages and standard deviations of OA signal amplitude and spectral 
components prior to, during and post laser heating of ex vivo bovine liver tissues 
(N=16). 
Spectral 
Parameter 
Prior to 
heating 
During 
heating  
Post 
heating 
t-test (p value) 
prior/      prior/       during/   
during     post          post 
OA 
midband 
fit (dB) 
5±1 10±2 12±1 <0.001 <0.001 0.0721 
OA slope 
(dB/MHz) 
1.73±0.04 1.43±0.03 1.42±0.02 <0.001 <0.001 0.4159 
OA 
intercept 
(dB) 
-2±1 5.2±2 7±1 <0.001 <0.001 0.0753 
OA signal 
amplitude 
(a.u.) 
0.01±0.02 0.7±0.3 0.7±0.2 <0.001 <0.001 0.4385 
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being applied.  Below 53°C the amplitude increases slowly, then around 55°C it 
increases more sharply.  This two-step increase in amplitude during heating has been 
reported by others 
46
, and is likely due to the rapid changes in optical scattering which 
occurs during coagulation.  Amplitude reaches a maximum value 9 times higher than 
signals prior to heating.  Increases similar to this of 2-4 times higher amplitude post-
treatment compared with pre-treatment have been reported by others 
46,47
.  When the 
laser is turned off and the temperature of the sample returns to its initial temperature, the 
amplitude does not decrease to its initial value, but remains 7 times higher than signals 
prior to heating.  This is indicative of a permanent change in a tissue property sensitive 
to OA wave generation (i.e. coagulation)  including the optical absorption and scattering 
coefficients, and Griuneisen parameter of the target 
11,17
.  Increased signal post-
treatment, after the tissue returns to its initial temperature, has also been reported by 
others 
46
.  
The midband fit and intercept increased during laser heating of the liver (to 
maximum of 7 and 8 dB higher than pre-treatment values). However, unlike the OA 
amplitude values, these components reached a maximum after approximately three 
minutes of heating and remained at that maximum even when the laser is turned off and 
the sample returns to its initial temperature.  Although these components are affected by 
the amplitude of the OA signal (and therefore the temperature of the target), they are 
more strongly affected by the tissue state which is made apparent by the fact that post-
treatment, as the temperature decreases, these frequency components remain stable.  We 
posit that as the tissue coagulation is initiated, the components increase to a maximum 
value, within 2-3 minutes, which indicates that the majority of the tissue within the ROI 
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had reached a state of coagulation, and the components remain at this value even as the 
temperature continues to increase within the sample.  During the first 2 minutes of 
treatment, the coagulation zone commonly increases rapidly in diameter and then slows 
down as heating continues 
46,48
.  The slope decreased to a minimum (0.31 dB less than 
pre-treatment values) within 2 minutes of heating.  This parameter may be an even more 
sensitive measure of tissue change as it is not affected by the amplitude of the OA signal 
(and thus it is likely not affected by the tissue temperature directly).  The calculated 
thermal dose versus the spectral parameter values shows that the three parameters reach 
a „steady state‟ at approximately 120 equivalent minutes at 43°C (within the range of 
thermal dose at which liver tissue coagulates ex vivo).  When the CEM43 value exceeds a 
critical threshold, the tissue is considered to be thermally coagulated. Thresholds for 
CEM43 have been tabulated in the literature for several types of tissue based upon 
experimental observation of tissue injury at 43°C.  The critical threshold value for ex 
vivo liver tissue ranges from 80 to 340 equivalent minutes at 43°C 
41,42
.   
When the laser is turned off the frequency components are not affected likely 
because the tissue remains in a coagulated state even as its temperature decreases.  It is 
known that the frequency of an OA signal depends on the physical characteristics of the 
target, therefore, as the physical characteristics of the target change (e.g. due to 
coagulation) we should expect to see changes to the frequency.  However, there is still a 
need to better understand the sensitivity among the frequency metrics and the tissue 
property changes during heating.  Future experiments will aim at understanding these 
relationships. 
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Changes to the pressure amplitude (OA signal) with temperature increase is 
greater than the changes in acoustic properties and the chemical content of the tissue 
46
.  
Therefore, OA imaging has the potential to be more sensitive to temperature changes 
than ultrasound imaging.  The sensitivity of OA amplitude, however, is dependent on 
the number of signals which can be acquired and often the number of signals acquired is 
limited by the necessity to achieve practical imaging time 
16
.  An additional challenge 
with using OA amplitude to monitor temperature is that as the tissue coagulates, its 
optical and physical properties change, and thus, the amplitude is affected by both the 
changing temperature and the changing optical and  physical properties of the tissue 
during coagulation 
47
.  It has proven difficult to decouple the influences of thermally 
induced changes in tissue optical and physical property (which are tissue- specific) and 
that of temperature on OA signals acquired during tissue heating.  The frequency 
analysis of OA signals described herein provides an additional analysis technique which 
is shown to be more sensitive than amplitude at detecting changes to the tissue during 
heating (which would allow for smaller sample size without sacrificing sensitivity).  
Furthermore, the frequency components are not highly affected by temperature, and 
thus, we propose they are affected by the changes to the optical and physical properties 
of the tissue. 
Overall the results of this study demonstrate that while the OA amplitude is 
sensitive to temperature changes, the frequency components of the OA signals may 
prove to be a more direct measure of tissue damage. Such OA frequency analysis in 
combination with OA thermometry may prove to be an improved strategy for 
monitoring laser thermal therapy.    
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CHAPTER 5 
OPTOACOUSTIC CHARACTERIZATION OF HEPATIC AND RENAL 
VASCULATURE USING VASCULAR CORROSION CASTS, IN VIVO TISSUES 
AND MATHEMATICALLY SIMULATED MODELS 
 
“How wonderful that we have met with a paradox. Now we have some hope of making 
progress.”  
-Niels Bohr (1885-1962) 
picture from http://www.goodreads.com/author/show/821936.Niels_Bohr 
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5.1  Introduction 
 The diagnosis of cancer is often based on qualitative data obtained through an 
invasive tissue biopsies procedure 
1
.  Quantitative data on the tumours' unique vascular 
network, however, may elucidate a better understanding of its aggressiveness, and 
facilitate improved treatment planning 
2,3
.  Ideally, this would be obtained via a non-
invasive technique. Many solid tumours are characterized by unique vascular networks  
(e.g. vessel diameter; density; branching angles) compared with normal, healthy tissues 
1
.  Most strikingly, tumour capillaries are often more tortuous, leaky, dense and 
disorganized than normal capillaries making the evaluation of the vascular components 
of neoplasms a viable approach for detecting them 
4,5
.   
 Currently, the most common quantitative analysis of tumour microvasculature 
used in preclinical models is histological diagnosis 
3
.  However, the cut surface dictates 
a view of the tumour which is a randomly selected two-dimensional slice of the mass, 
making it difficult to be confident that it is representative of a complex three-
dimensional structure 
6,7
.  Intravital microscopy is an emerging technique that has 
enabled in vivo detection of orthotopic tumours (implantated tumours into their 
originating tissue) 
8,9
.  This approach allows for submicrometer lateral resolution and 
three-dimensional reconstructions, however it suffers from its lack of flexibility with 
respect to the microscope body and lenses 
8
.  For this technique to be maximally 
effective, the surface of the tumour should be flat, which is rarely the case 
8
.   
Optoacoustic imaging has the ability to image vascular structures with high 
contrast and high resolution 
10,11
.  The majority of the OA systems, presented in recent 
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literature, describe the ability to image vasculature with high resolution (e.g. less than 
0.5 mm) and deep penetration (e.g. greater than 5 mm) using spherical or cylindrical 
detection geometries 
12,13
 (see section 1.6).  These detection geometries are ideal for 
accurate OA image reconstruction, and provide high contrast and resolution in real time.  
However, these geometries are constrained by the need for access to all sides of the 
target.  They are not suitable for imaging superficial structures, such as the skin, or if 
strongly echogenic structures such as bone or lung are situated along the acoustic 
propagation path (as is the case for the prostate) 
10
.  These circumstances call for more 
versatile planar detection geometry in which detection is performed over a finite plane 
using a one or two-dimensional ultrasound array 
10
.  The OA imaging systems that 
employ this geometry often resemble conventional ultrasound imaging systems.  
Frequently OA imaging instruments may use existing clinical ultrasound scanners, 
sufficiently modified, so that the RF (radio frequency) acquisition can be triggered by 
the excitation laser in order to detect OA waves as well as ultrasound echoes 
14–18
.  Co-
registration of the OA and ultrasound images is then relatively straightforward and 
absorption-based contrast, from the OA image, can provide structural and functional 
information about the vasculature, while the ultrasound image provides information on 
the tissue morphology based on elasto-mechanical properties 
10,19
.   
Real-time optoacoustic imaging has been demonstrated using planar geometry 
detection to visualize tumours in vivo (see section 1.6).  However, the resolution 
associated with these images rarely matches that of spherical/cylindrical detection 
systems  
20
.  Three-dimensional, high-resolution OA images can also be acquired using 
planar detection systems as shown by Laufer et. al. 
21
 (see section 1.6).  However, these 
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images necessitate axial and lateral mechanical scanning which consequently increases 
imaging time.  This imaging time remains a common limiting factor for three-
dimensional planar detection systems limiting applicability for clinical use 
22,23
. 
 Thus, planar detection geometry, although ideal for clinical use, lacks the 
necessary resolution or cannot be performed in real time 
10
.  In order to overcome these 
limitations, the mechanical scanning speed must be increased (limited, and often itself 
introduces artifacts) or the resolution of two-dimensional OA images must be improved.   
An indirect means of improving the resolution of OA images may exist in the 
alternative analyses of the detected signal.  In addition to the amplitude, the frequency 
content of the OA signals may provide sub-resolution information, making two-
dimensional, relatively low-resolution OA images more viable for clinical use.  Even if 
vascular structures themselves are not resolved in the reconstructed images 
(reconstruction often loses a great deal of information, particularly the sub-resolution 
detail 
24
), frequency content of the generated OA signals may be used to identify regions 
in the tissues with specific vascular characteristics which may indicate the presence of 
disease 
25
.  This may provide essential information about the target that replaces the 
need for very high resolution imaging, which is associated with long acquisition times 
when using planar detection geometry.   
The information content of a transducer‟s signals is related to the frequency 
response and the field profile of the transducer 
26
.  As the number of transducer locations 
decreases, limiting the system‟s resolution, the information content from each individual 
signal remains unchanged.  There is significant information with sub-resolution detail 
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contained in each OA signal 
27,28
.    For example, it is known that the size and 
concentration of the optical absorber dictates the frequency content of the OA RF 
signals 
29,30
.  Work is ongoing to identify how other target characteristics are manifested 
in the frequency content of the OA signals as well 
25,31
. 
5.1.1  Hepatic and renal vasculature 
Hepatic and renal vascular characteristics (including root vessel diameter, 
branching angle, relative vessel sizes and density) differ significantly in several strains 
of adult mice 
32–34
.  However, these differences are minimal compared with the 
differences between normal/healthy vasculature and neoplastic vasculature 
32
.  The 
ability to discriminate these two tissues would, therefore, imply that discriminating 
between normal and neoplastic tissue, based on their different vascular characteristics, is 
conceivable.   
Healthy hepatic and renal vascular characteristics in the mouse have been well 
documented 
1,33–35
.      Mouse hepatic and renal vessels and capillaries range in diameter 
from approximately 5 µm to 200 µm.  Hepatic vessels of adult female nude mice are on 
average, approximately 10 μm, while renal vessels are slightly larger at approximately 
15 μm on average 1.  Average vessel densities are approximately 6 and 3 % length/area 
for hepatic and renal vascular, respectively 
1
.  Therefore, averaged over the entire organs 
(in several strains of adult mice) hepatic vessels are smaller and more dense than renal 
vessels (see Results, Figure 5.7) 
33–36
. 
5.1.2  Vascular corrosion casts 
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Vascular corrosion casting is a standard method of visualizing the three-
dimensional architecture of a vascular network, and involves injecting a casting material 
into the circulatory system of the animal, which quickly polymerizes into a hardened 
plastic cast 
37
.  Tissues are then corroded away, leaving behind a detailed cast of the 
circulatory system.   
The casting material used can significantly affect the quality of the resulting cast, 
and should have low viscosity, quick and even polymerization, minimal shrinkage 
during drying, and resistance to corrosion during cleaning, dissection and drying.   Latex 
and silicone rubber have been used due to their low viscosity and low resistance to 
corrosion but result in inconsistent replication of luminal surface microstructures 
37
.  
Polyurethane based resin (PU4ii), which has low viscosity, quick polymerization, 
minimal shrinkage and is highly elastic post-casting, is an emerging compound for 
vascular casting 
32
.    However, the most common material for constructing casts, and 
that which was chosen for this study, is methyl methacrylate (Mercox®) which has  a 
low viscosity, quick polymerization, minimal shrinkage and results have been well 
documented  
32
.  Mercox® has the ability to infiltrate capillaries as small as 5 µm in 
diameter 
38
.  The limiting resolution of vascular casts is therefore often in the CT images 
which are used to observe the capillaries.  A relatively high-resolution CT system (e.g. 
micro-CT) would have a resolution of approximately 15 -30 μm1.  When hardened, 
resins similar to Mercox® have a Grüneisen parameter of approximately 5 compared 
with soft tissue which has a Grüneisen parameter of typically less than 1 at between 20-
40 °C 
39,40
.   
5.1.3  Computer simulation of vasculature 
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There are several methods used to generate models of vasculature in tissue.  The 
goal of all of these approaches is to mimic the tissue with parameters based on actual 
physical characteristics.  Vascular networks of an organ with blood flow considerations 
were modeled by Kretowski et al. (2003) who simulated the vascular geometry by 
simulating the process of vessel formation 
41,42
.  Kurz and Godde (2001) used cellular 
automaton to simulate angiogenisis and vascular remodeling 
43
.   Turing reported using 
activator inhibitor models to record the transfer of chemical signals 
44
.  Wang et al. 
(2007) described the generation of realistic vascular branching patters by using Markov 
probability models based on actual vasculature 
45
.  Zamir (2001) and Kharchakdjian 
(2001) also modeled renal vascular tissue, using fractral trees consisting of many 
branching vessel segments 
46,47
. 
A fractal tree is a mathematical structure that is formed by iteratively applying a 
branching pattern to the result from the previous iteration. The pattern is specified as a 
relationship between the parent segment, the left child segment and the right child 
segment. Here, the terms "left" and "right" are mathematical conventions and do not 
necessarily correspond to the physical directions for which they are named. 
A single iteration of the fractal tree pattern is shown in Figure 5.1. Three 
segments are connected in a Y-shaped configuration. Each segment is a finite-length 
cylinder with length L and diameter D. The child segments meet the parent segment at a 
junction located at the end of the parent segment. The angle at which a child branch 
diverges from the parent segment is called θ. The rotation of a child branch with respect  
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Figure 5.1: Fractal tree pattern used to model vascular morphology adapted from Zavel 
48
. The posterior end of the parent segment splits into two child segments. Each child 
segment becomes a parent segment in the succeeding iteration 
48
.  
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to a reference plane through the parent is given by the angle ø 
26
.  The diameter 
asymmetry (also called the bifurcation index) is defined as; 
    βi = DR/DL 0 ≤βi≤ 1 
 
where DR and DL are the diameters of the right and left child branches respectively.  A 
uniform probability distribution is used to induce randomness into the branching 
structure.  This fractal pattern is repeated upon multiple iterations. 
Simulation of vascular networks using fractal trees is a convenient method for 
generating datasets of tissue. The mathematical structure of the fractal tree model allows 
specific morphological parameters to be varied in a deliberate way which facilitates 
controlled testing 
26
.  Quantitative validation of the use of fractal trees for simulating 
human liver has found that there is up to 85% agreement between the simulation and 
casts of human hepatic vasculature 
49
.  Fractal tree simulations may also be used to 
assess morphological and functional properties of biological tissues based on their 
fractal nature 
50
.  Clinically, fractal tree simulations have also been used for surgery 
planning of split-liver transplants and tumor resection with much success 
51
.  
Based on structural morphology, we postulated that it would be possible to 
differentiate between different sub-resolution vascular morphologies using optoacoustic 
techniques.  In this study, we aimed to investigate: the relationships between the size and 
concentration of OA targets and the frequency spectrum of the detected OA signals, and 
the ability of OA imaging to distinguish two sub-resolution vascular structures (hepatic 
and renal vasculature), via frequency analysis of the OA RF signals. 
 5.2  Materials and Methods 
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 All procedures performed in this study were approved by the Animal Care 
Committee of the University of Prince Edward Island, and were written in accordance 
with the guidelines of the Canadian Council for Animal Care.   The following methods 
were used to achieve the above objectives.   
5.2.1  Polystyrene microsphere phantoms 
 Tissue-mimicking phantoms were constructed using gelatin powder derived from 
porcine skin (Sigma-Aldrich Co., St. Louis, MO) and black polystyrene microspheres 
(Polyscience Inc., Warrington, PA) as spherical absorbers with diameters of 10 μm, 50 
μm and 100 μm.  These diameters were chosen to represent the approximate published 
diameter range (5 μm for smaller capillaries, to 100-200 μm for larger vessels 52) of 
vessels and capillaries that are found in murine hepatic and renal vasculature 
53,54
 .  
Phantom preparation involved mixing the microspheres with degassed water which was 
then heated to approximately 80 
o
C.  The gelatin powder was added and mixed until it 
had completely dissolved (approximately 10 minutes).  This solution was then poured 
into phantom molds (measuring 4 cm by 4 cm by 2 cm) which were then cooled to 4
o
C 
for at least 2.5 hours.  For each phantom, 4 g of gelatin was mixed with 40 mL of 
degassed water.  For each microsphere size, three different phantoms were constructed 
with the following concentrations of microspheres: 0.1, 0.2 and 0.3% (v/v), by mixing 
the appropriate amount of microspheres with degassed water prior to heating.    
Optoacoustic signals were obtained at 50 unique locations, within 3 different 
regions of interest (ROIs; 2 mm x 2 mm) on each phantom (Figure 5.2) using the SENO 
optoacoustic imaging system. Twenty-seven ROIs from nine phantoms were imaged in  
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Figure 5.2:  a) Photograph of three gelatin phantoms with 50 μm spheres at 0.3, 0.2 and 
0.1% concentrations in molds.  Three regions of interest (2 mm x 2 mm) were imaged 
on each phantom as shown on b) the phantom schematic.  Fifty signals were acquired 
within each region. 
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total.  Sample size was determined by performing a power analysis using results of a 
similar study 
55
.  Images were acquired using laser fluence of 2.5 W at 775 nm, and 0.2 
mm step size. 
Each image was recorded in duplicate to verify that there was no significant 
intra-sample variation between image acquisitions.  Amplitude and frequency analysis 
was performed on all OA signals acquired. 
5.2.2  Vascular corrosion casts 
Vascular corrosion casts were created using methyl methacrylate (Mercox®) 
32
 .   
Casts were prepared as described by Giuvảrảşteanu (2007) 37. Prior to casting, four 
C57Bl/6 mice were transcardially perfused with 20 ml of saline.  The catalyst (2 ml;  
Benzoyl Peroxide (40%)) was added to 20 ml of Mercox® and stirred until completely 
dissolved.  This 22 ml solution was injected into the left ventricle of the mouse using a 
20 ml syringe at a constant rate (10 ml/min) until the liquid exiting the pericardium 
turned red. For 30 minutes post injection the animal remained undisturbed to allow the 
casting medium to harden. The tissue surrounding the casting medium was removed by 
immersing the animal into sodium hydroxide (40%) for 3 days.  The sodium hydroxide 
solution was changed once per day. The casts were washed in distilled water to remove 
any white saponified materials and air dried in a fume hood for 24 hours.   
The casts were embedded into gelatin derived from porcine skin (Sigma-Aldrich 
Co., St. Louis, MO) prior to OA imaging.  Optoacoustic signals were acquired in a 2 by 
2 mm
2
 ROI centered on each of the three cast organs (liver and two kidneys). Signals 
were acquired every 0.2 mm within the ROI for a total of 100 signals.  Images were 
acquired using laser fluence of 2.5 W at 775 nm, and 0.2 mm step size (identical to those 
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used for imaging microsphere phantoms). 
5.2.3  Computed tomography of vascular corrosion casts  
Computed tomography (CT) images of four vascular casts (each containing one 
liver and two kidneys) were obtained using a micro-CT imaging system (Siemens 
Inveon Micro-CT).  The system has a 12-cm bore for small animal imaging and a 10 x 
10 cm field of view and is equipped with a variable focal spot X-ray source. The CT 
protocol used in this study was designed to represent a scan that might be typical for 
whole-body mouse imaging.  CT set up included 210 degrees of rotation, acquiring 210 
projections (i.e. 1 projection acquired per degree of rotation).  The x-ray tube had a 
voltage of 80 kV and a current of 500 μA.  Exposure time was 5100 ms/projection, with 
an effective pixel size of 13.32 μm and a field of view of 40.9 mm (transaxial) by 27.27 
mm (axial).  Reconstructions were done by slice rather than by volume using Shepp-
Logan reconstruction filter and bilinear interpolation 
56
.   
Vessel diameters and relative densities of the blood vessels within the hepatic 
and renal vascular casts were measured manually in the reconstructed images using 
ImageJ® software 
37
.  
5.2.4 Computer simulation of vascular trees and associated theoretical OA 
signals 
Murine hepatic and renal vasculature were simulated using a Matlab R2009b 
(The Math Works, Inc, Natick, MA) based script which involved simulating blood 
vessel networks with fractal trees 
26
. The fractal trees were generated using published 
values of murine hepatic and renal characteristics, and values measured in the micro-CT 
images.  For the kidneys these values were: branching angle 25° 
48
, diameters 10-100 
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μm 53(not including parent vessel diameter), and density 3.5 %length/area 1.  For the 
liver these values were: branching angle 25° 
48
, diameters 5-100 μm 1,53 (not including 
parent vessel diameter) and density 5.5 % length/area 
1
,  Values measured in the micro-
CT images of the casts were parent diameters of 250 μm and 300 μm for kidney and 
liver respectively,  and density of 3 and 5 % length/area for kidney and liver 
respectively.  Simple spherical source geometry was used to model OA sources, and 
simulated theoretical OA signals generated by each fractal tree.  The theoretical 
transducer used in this script had a 1 MHz central frequency with a -6 dB bandwidth of 
60%.  Validation of the simulator has been performed by Zalev et al. (2010) against a 
derived exact equation for finite-length cylindrical OA sources and through finite 
element method (FEM) models 
26
. 
5.2.5  In vivo optoacoustic imaging 
All procedures performed in the in vivo portion of this study were approved by 
the Animal Care Committee of the University of Prince Edward Island, and were 
conducted in accordance with the guidelines of the Canadian Council for Animal Care.  
Nine adult C57Bl /6 male mice were used in this study.  Prior to imaging, each animal 
was placed in an anesthetic induction chamber and anesthetized with 4% isoflurane in 
100% oxygen. Once anesthetized, the hair on the lower abdomen of the animal was 
removed using a chemical hair remover (Nair ®, Church & Dwight Corporation Inc., 
ON, Canada).  Animals were maintained under general anesthesia, secured to a vertical 
holder, and lowered up to the neck level into a water-bath which held the laser fibers 
and the transducer. The imaging system is described in detail in Chapter 2, Materials 
and Methods.  Images were acquired using laser fluence of 2.5 W at 775 nm, and 0.2 
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mm step size.  ROI‟s of approximately 5 mm x 5 mm were imaged.  Analysis was 
performed on 2 mm x 2 mm ROI‟s centered on the target organs (liver and kidneys). 
 Immediately following the image acquisition, animals were euthanized via 
intracardiac injection of sodium pentobarbital (Euthanyl, Supplier, Location; 65 mg/kg).  
The animals were then flash frozen in liquid nitrogen (approximately -190 °C) in an 
upright position on the holder to reduce organ migration.  The abdomen was dissected, 
and 100 µm lateral cryosections were acquired using a cryostat for gross anatomical 
comparison with the OA images.   
5.2.6  Optoacoustic data analysis 
 The analysis of each data set was performed using an in-house built script 
written using Matlab R2009b (The Math Works, Inc, Natick, MA).  The Hilbert 
transform was applied to the RF data 
57,58
.  The signal strength is presented in arbitrary 
units and all data were collected with the same constant gain settings.   
In order to account for optical attenuation by tissues which reduces the light 
available at depth for OA wave generation, we have employed a depth-dependent signal 
correction to each A-line. This is somewhat analogous to the use of time gain controls 
(TGC) in ultrasound imaging to account for acoustic attenuation, However, optical 
attenuation is significantly greater than the acoustic attenuation below 10 MHz in tissues 
58
.  For a non-collimated laser beam incident on tissue, the light intensity, decays 
exponentially according to [1],   
            
            [1] 
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where μeff is the effective attenuation coefficient and z is the depth.  An effective optical 
attenuation coefficient of 1.9 cm
-1
 was used (average of mouse skin, fat and muscle 
attenuation coefficient) 
59
.  The final form of the correction factor was 
                       
            [2] 
 A MATLAB® (The MathWorks Inc.) based script was developed and used to 
apply the attenuation estimate to the signals.   Such a correction is important given the 
variation in liver and kidney depths in mice 
37
.   
 The signal amplitude was calculated by integrating each signal envelope 
(obtained by taking the Hilbert transform).  Average signal amplitude values were 
calculated for liver and kidney within the ROI on each organ 
60
.     
5.2.7  Optoacoustic frequency spectrum analysis 
 A spectrum analysis technique previously described for OA RF data was used 
for this analysis (Chapter 2, Material and Methods).   
 The FFT was applied to the RF data to calculate the RF echo spectrum.  The 
mean of the squared spectral magnitudes is the averaged power spectrum (APS).  The 
APS was converted into the decibel (dB) scale.  The transducer‟s power spectrum was 
subtracted from the converted APS to remove any system-specific artifacts caused by 
transducer and imaging device.    
 A sliding Hamming window was employed in order to localize the signal from 
the sample as well as minimize spectral leakage 
61
.  The Hamming window had a width 
of 1 mm and moved in 0.5 mm steps along the axial direction.   
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A linear fit was applied to the calibrated power spectrum between 1 and 6 MHz.   
This region was chosen based on the approximate linearity of the dataset and the high 
signal to noise (SNR of >3 dB) within these frequencies. The signal to noise ratio 
decreased to close to 1 when the frequencies were above 6 MHz.  At the extremely low 
frequencies (below 1 MHz), a very strong spectrum amplitude is observed.  This, 
however, is not from the illumination of the targets (microsphere or casts), but instead 
from the residual background signal caused by the illumination on the gel 
25
.  The 
midband fit, intercept and slope of the linear fit were calculated and defined as the 
spectral parameters.   
Using the slope and the midband fit together, size and concentration of OA 
targets can be inferred.  If the slope of target 'A' is higher than the slope of target 'B' then 
it was deduced that target 'A' is smaller in size than target 'B'.  Therefore, the midband 
fit of target 'A' was lower than that of target 'B' at similar concentrations.  If the midband 
fit of 'A' was less than that of 'B' then the concentration of 'A' was considered less than 
or equal to that of 'B'.  If the midband fit of 'A' was greater than that of 'B' then the 
concentration of 'A' was found to be greater than that of 'B'. 
A two-way ANOVA was used to compare the signal amplitudes and spectral 
parameters of the microsphere phantoms.  A paired t-test for different sample sizes was 
used to compare the signal amplitudes and spectral parameters between hepatic and 
renal vascular casts and tissue in vivo. A p-value of 0.05 or less was used to establish 
statistically significant differences. 
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5.3  Results 
5.3.1  Polystyrene microsphere phantoms 
Representative OA signals from 10, 50 and 100 μm microsphere phantoms all 
with a 0.3% (v/v) concentration are presented in Figure 5.3.  The integrated signal 
amplitude for all phantoms are presented in Figure 5.4 and summarized in Table 5.1.  
 Figure 5.5 presents representative power spectrum (APS) of the 50 µm, 0.2% 
microsphere phantom, the transducer's power spectrum and the calibrated spectrum.  
The portion of the calibrated APS curve between 1 and 6 MHz was fitted using a linear 
equation, and the slope, intercept and midband fit of the linear fit were recorded.  These 
variables are defined as the spectral parameters.  
The spectral parameters (slope, midband fit and intercept) for the phantoms are 
presented in Figure 5.6 and summarized in Table 5.1.  The OA signal amplitude 
increased with increasing concentration (of the same size microsphere) and increasing 
size of microspheres.  The amplitude was approximately 32% higher for 100 μm spheres 
compared with 10 μm spheres.  Significant differences (p<0.05) in OA amplitude were 
found between each size of sphere at every concentration, and between each 
concentration at every size.  Interaction between the size and concentration of the 
spheres was not significant (p = 0.1841).  There was no significant difference between 
the amplitude values at different concentrations (when the values of all three sizes were 
included).  The spectral slope decreased significantly with increasing microsphere size   
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Figure 5.3:  Representative optoacoustic signals (Hilbert transformed) for a) 10, b) 50 
and c) 100 μm microsphere phantoms of 0.3% (v/v) concentration. 
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Figure 5.4:  Integrated signal amplitude (area under the curve) in arbitrary units for 
each size and concentration of polystyrene microsphere (N=3).  Error bars represent one 
standard deviation. 
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Figure 5.5: Representative power spectrums of; a) uncalibrated radio frequency 
spectrum and calibration spectrum of the 5 MHz transducer, b) The calibrated power 
spectrum and linear fit applied between 1 and 6 MHz.  
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Figure 5.6:  Spectral parameters (slope, midband fit and intercept) of polystyrene 
phantoms with varying sphere concentration and size.  Error bars represent one standard 
deviation (N=3). 
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Table 5.1:  Mean (+ standard deviation) integrated optoacoustic signal amplitude and 
spectral parameterss (slope, midband fit and intercepts) for 10, 50 and 100 μm 
polystyrene microspheres at concentrations of 0.1, 0.2 and 0.3%. N=3. 
       Phantom 
Parameter 
10 μm 50 μm 100 μm 
0.1% 0.2% 0.3% 0.1% 0.2% 0.3% 0.1% 0.2% 0.3% 
Signal amplitude 
(a.u) 
1.5 
±0.1 
1.55 
±0.05 
1.6 
±0.1 
1.8 
±0.1 
1.8 
±0.1 
1.9 
±0.1 
2.0 
±0.1 
2.0 
±0.1 
2.11 
±0.05 
Slope (dB/MHz) 1.4 
±0.1 
1.3 
±0.1 
1.4 
±0.1 
1.1 
±0.1 
1.2 
±0.1 
1.1 
±0.1 
0.6 
±0.1 
0.5 
±0.1 
0.6 
±0.1 
Midband    
fit (dB) 
-4.9 
±0.2 
-3.2 
±0.2 
-2.9 
±0.2 
-2.9 
±0.2 
-1.5 
±0.2 
-1.0 
±0.2 
-1.0 
±0.2 
-0.9 
±0.2 
-0.6 
±0.2 
Intercept (dB) -11.8 
±0.8 
-9.9 
±0.2 
-9.2 
±0.4 
-7.8 
±0.2 
-7.4 
±0.2 
-7.9 
±0.9 
-4.0 
±0.3 
-4.1 
±0.1 
-3.2 
±0.3 
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(p-value <0.001) and was unchanged with increasing concentration (p-value 0.6766).  
The midband fit significantly increased with increasing size of microsphere (p-value 
<0.001).  As with amplitude, there was no significant difference between the midband 
fit values at different concentrations (when the values of all three sizes were included) 
(p-value 0.8440), however, the midband fit value did increase with concentration if size 
was kept constant.   The intercept value significantly increased with increasing size of 
microsphere (p-value 0.0162). There were no significant differences between the 
intercept values between different concentrations (0.8564). 
5.3.2  Vascular corrosion casts 
Figure 5.7 shows representative images of murine hepatic and renal vascular 
casts. Representative OA signals from hepatic and renal vascular casts are shown in 
Figure 5.8.  Integrated OA signal amplitude values of 0.25 ± 0.06 and 0.21 ± 0.07 were 
found for hepatic and renal vascular casts respectively.  No significant differences were 
found between the average signal amplitude of each casted organ (p=0.1207). 
Spectral parameters from hepatic and renal vascular casts are shown in Figure 
5.9.  There were no significant differences found in any of the spectral parameters 
between the casts of the left and right kidney (data not shown).  Mean and standard 
deviation values for both casted tissues are presented in Table 5.2.  Each of the spectral 
parameters was significantly higher for liver compared with kidney casts.   
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Figure 5.7: Representative images of murine vascular corrosion casts of a) kidneys, b) 
liver.  Mercox® resin was injected into a perfused mouse at a constant rate and allowed 
to harden.  The tissues of the mouse were removed by immersing the body into 40% 
sodium hydroxide.  The kidney and liver were dissected from the cast after removing the 
overlaying tissue. 
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Figure 5.8: Representative optoacoustic signals of a) kidney and b) liver corrosion 
casts.  
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Figure 5.9:  Spectral parameters (midband fit, intercept and slope) of optoacoustic 
signal from liver (N=3) and kidney (N=6) casted tissues.  
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Table 5.2: Average (+ standard deviation) variability of spectral parameters of murine 
hepatic (N=3) and renal (N=6) vascular casts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spectral Parameter Liver cast Kidney cast Paired t-test  
(p value) 
midband fit (dB) 14±1 3±2 <0.001 
slope (dB/MHz) 1.5±0.1 1.0±0.2 <0.001 
intercept (dB) 9±1 -1±3 <0.001 
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5.3.3  Computer simulation of vascular trees and associated theoretical OA 
signals 
 Representative two-dimensional images of computer simulated hepatic and renal 
vasculature are presented in Figure 5.10.  The associated OA signals of each vascular 
tree were simulated using the software, and frequency analysis was performed using the 
same software as was used to analyze the microsphere data.  The power spectrum and 
calibrated power spectrum are presented in Figure 5.11.  The frequency parameters of 
both simulated vasculatures are presented in Table 5.3. 
Calibration of the RF spectrum was done using a power spectrum of a transducer 
with the characteristics of that used to simulate data (i.e. single point element, 1 MHz 
central frequency). 
5.3.4  In vivo murine model  
An axial cryosection image of the gross anatomy of the liver and kidney region 
of a mouse is shown in Figure 5.12.  Due to natural variations in the positions of the 
kidneys with respect to the liver and the small imaging window, not all kidneys were 
within the imaged area in all nine animals and thus, only data from 13 of the 18 kidneys 
were available for further anlaysis.   Integrated signal amplitude values of hepatic and 
renal tissues are shown in Figure 5.13.  Average integrated OA signal amplitude values 
of 2.4 ± 0.9 and 2.1 ± 0.9 were found for hepatic and renal tissues respectively.   No 
significant differences were found between these two values (p = 0.4464). 
Spectral parameters from hepatic and renal vasculature are shown in Figure 5.14.  
There were no significant differences found in any of the spectral parameters between  
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Figure 5.10:  Two-dimensional images of vascular trees simulated to represent a) 
kidney vasculature and b) liver vasculature.   
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Figure 5.11:  Representative power spectrums of simulated hepatic and renal  
vasculature. a) Uncalibrated RF simulated tissue spectrums, b) Calibrated simulated 
tissue power spectrums and linear fits applied between 1 and 6 MHz. 
 
 
 
 
 
 
 
0 2 4 6 8 10
-20
-18
-16
-14
-12
-10
-8
-6
-4
-2
Frequency (MHz)
A
m
p
lit
u
d
e
 (
d
B
)
 
 
Liver spectrum
Kidney spectrum
1 2 3 4 5 6
8
10
12
14
16
18
20
22
24
Frequency (MHz)
A
m
p
lit
u
d
e
 (
d
B
)
 
 
Liver calibrated spectrum
Linear fit
Kidney calibrated spectrum
Linear fit
a) b)
175 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3:  Average ± standard deviations of spectral parameters of simulated murine 
hepatic and renal vasculature.  Uncertainties were defined by varying the vascular 
characteristics within their spectrum of values given in literature.  N=3. 
Simulated organ  Intercept (dB)  Slope (dB/MHz)  Midband fit (dB)  
Kidney  6.2±0.8 1.42±0.03  12.5±0.7  
Liver  8.2±0.6  1.50±0.02  14.9±0.5  
   
 
 
 
 
 
 
 
 
176 
 
 
 
 
 
 
 
 
Figure 5.12:  Representative Axial cryosection of the liver and kidney region of a 
C57Bl/6 mouse (photograph by M. Arsenault). 
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Figure 5.13: Integrated signal amplitude values of optoacoustic signal from liver and 
kidney tissues of nine C57Bl/6 mice.  Error bars represent one standard deviation. 
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Figure 5.14:  Spectral parameters (slope, midband fit, and intercept) of optoacoustic 
signals from liver (N=9) and kidney (N=13) tissues of nine C57Bl/6 mice.  Error bars 
represent one standard deviation. 
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the left and right kidneys (data not shown).  Mean and standard deviation values for both 
tissues are presented in Table 5.4.   
Midband fit and slope were higher on liver compared with kidney tissue.  No 
significant difference was found between the intercept values of the two tissues. 
5.4  Discussion and Conclusions 
 This study demonstrates the potential for OA imaging to be used to discriminate 
size and concentration of sub-resolution OA sources (microspheres, and cast, simulated 
and in vivo blood vessels).  When reconstructed, the RF signals acquired in this study, 
did not resolve these individual targets (data not shown).  However, when frequency 
analysis was performed, structural characteristics of these un-resolvable structures were 
determined.  The frequency spectrum of these RF signals was sensitive to the changes in 
size and concentration of absorbers (microspheres) and thus, was successful in 
discriminating between tissues with different vascular densities and vessel size 
distributions (e.g. hepatic and renal vascular).  The ability of these two tissues to be 
discriminated by OA frequency analysis was investigated using vascular corrosion casts, 
in vivo tissues, as well as computer simulated vasculature.   To our knowledge, this is 
the first study which demonstrates the ability to discriminate between healthy sub-
resolution vasculature using OA frequency analysis via three different media.   
 Phantom and simulation studies by Yang et al. (2012) and Xu et al. (2012) 
experimentally confirmed the feasibility of discriminating target size and concentrations 
based on the OA frequency spectrum characteristics 
25,31
.  A similar phantom was  
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Table 5.4: Average ± standard deviations of spectral parameters on murine liver (N=9) 
and kidney (N=13) tissues.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Spectral Parameter Liver Kidney  t-test (p value) 
midband fit (dB) 3.4±0.9 0.8±0.3 <0.001 
slope (dB/MHz) 1.4±0.3 0.6±0.2 <0.001 
intercept (dB) -1.7±0.8 -1.5±0.5 0.5434 
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employed (microspheres embedded in porcine gelatin) by Xu et al. (2004) and found 
similar trends in the spectral parameters to those presented in this study 
25
.  The absolute 
values of the parameters, however, could not be compared as the diameters and 
concentrations of the microspheres were greater than those used in this study 
25
.  As the 
size of the optical absorber (polystyrene microsphere) increased, the corresponding OA 
signal amplitude also increased (Figure 5.4).  This agrees with theoretical solutions to 
the wave equations which predict that with simple geometries, the amplitude of the 
pressure wave (i.e. signal) is proportional to the radius of the absorber squared 
29
.  If the 
size is kept constant, the amplitude also increases with increasing concentration of 
absorber.   
 The slope spectral parameter decreased as the size of the absorber increased 
(Figure 5.6).  A target with a larger diameter generates a signal with a lower frequency 
compared with a smaller target.  Therefore, it is reasonable to expect that absorbers with 
larger diameters would result in smaller slopes 
25,30
.   However, upon closer inspection, 
there does appear to be a discrepancy between the theory presented by Oraevsky et al. 
(2000) and the results presented herein 
62
.  The portion of the power spectrum that was 
used for analysis in this study included only those frequencies between 1 and 6 MHz.  
According to Oraevsky et al. (2000) this band of frequencies would be generated largely 
by targets with diameters greater than 100 µm (the targets in this study were 10, 50 and 
100 µm in diameter) 
62
.  Therefore, the larger targets would more significantly affect 
these frequencies, and should increase the slope rather than decrease it.  However, this 
discrepancy may be explained by the presence of the overlying phantom material and 
the methodology used.  The gelatin phantom with no embedded microspheres produces 
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relatively strong low frequency (1-2 MHz) signals.  Therefore, the presence of the 
frequency increase centered at 10 MHz, due to the 100 µm targets, results in a more 
negative slope compared to the presence of the smaller targets which have less impact 
on the frequencies in the chosen range.  The methodology used herein involves the 
subtraction of the calibration spectrum which peaks at approximately 2 MHz.  Due to 
the sharp negative slope of the calibration spectrum, the subtraction of it results in a 
calibrated frequency spectrum with a positive slope. 
 The midband fit increased as the size of the absorber increased and as the 
concentration increased, similar to the amplitude.  Midband fit may be superior to 
amplitude based on the relative increases of each parameter with change in size and 
concentration of the target.  Signal amplitude varied by 0.61 a.u. with average standard 
deviation of 0.09 (15% of the variation) while the midband fit varied by 4.3 dB with an 
average standard deviation of 0.2 (5% of the variation).  This suggests that midband fit 
values are more sensitive to distinguishing between these target characteristics 
compared with amplitude.   
 During the process of frequency analysis a FFT is performed which yields a real 
and imaginary value.  Only the real value is used for analysis in this and other published 
OA and ultrasound frequency spectrum analysis techniques 
31,63,64
.  The imaginary value 
of the FFT may be important when estimating the scatterer size, if the data is noise 
65
.  
Some size estimates might turn out to be imaginary if the scatterers are very small (<5 
µm) 
65
.  The phantoms/vasculatures imaged herein, contained targets mostly greater than 
5 µm and, therefore, should not be significantly impacted by the imaginary value of the 
FFT. 
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 OA signals generated by the vascular casts of murine hepatic and renal vascular 
did not differ significantly in amplitude.  Therefore, there was no affect of amplitude on 
the differences between midband fit and intercept values of the casts.  The midband fit, 
intercept and slope values did differ significantly between the two casted tissues.  Based 
on the results of the microsphere phantoms, the differences found are, thus, more likely 
to be due to structural differences in the casts The higher slope value associated with the 
liver casts indicates that it has, on average, smaller vessels than the kidney cast.  
Assuming the two casted tissues had similar densities (but liver has smaller vessels) the 
midband fit would have been expected to be less on liver than on kidney.  The midband 
fit, however, was found to be greater on liver which indicates that the liver has a higher 
vessel density.  These results agree with published results of  hepatic and renal 
vasculature as well as with the characteristics which were measured in CT images of 
these vascular casts 
1
.  
 A theoretical 1 MHz central frequency was used to simulate the OA signals.  
Although a 5 MHz central frequency transducer was used herein, the transducer‟s power 
spectrum was similar to a 1 MHz transducer with a -6 dB bandwidth of 60% (this is 
most likely due to the system electronics which may decrease the frequency focus of the 
transducer during signal acquisition and processing).   The spectral parameters were all 
greater on liver compared with kidney which agrees with the experimentally acquired 
data.  The relative differences in each parameter were 2.0 for intercept, 0.08 for slope 
and 2.4 for midband fit.  These differences were approximately 80% lower than the 
experimentally acquired values; however, their associated uncertainties were also 80% 
lower.  The simulated kidney casts produced much higher signal amplitude and, 
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therefore, midband fit and intercept values, than the experimental kidney data while the 
simulated liver values were similar to the experimental values.  This is likely what 
caused the decrease in the spectral differences between the two organs.   Furthermore, in 
the case of slope, where the values are not affected by amplitude, the differences were 
similar among the experimental and simulated data.   The simulation script does not take 
into account wavelength or absorption differences and, therefore, the exact pressure 
values at the origins of the OA targets are unknown.  The absolute values of the 
generated OA signals are based only on size and relative density of the targets.  
 Similar trends were observed in the frequency response of the hepatic and renal 
vascular between experimental and simulated data.  Hepatic vasculature (both cast and 
simulated) generated signals with higher associated midband fit, slope and intercept 
values compared with renal.  A higher slope indicates smaller vessel sizes in the hepatic 
tissue.  Knowing this, if the concentration of vessels in the hepatic tissue were equal or 
less than that in the renal tissue, the midband fit of the hepatic tissue should be lower 
(smaller target size results in weaker signal, see Figure 5.6).  However, the hepatic tissue 
has a higher midband fit value, indicating that the concentration of vessels higher.  This 
agrees with published characteristics of these two tissues 
1
.   Similar differences in slope 
values were observed in two artificial, melanomas-like tumours with vessel diameters 
averaging 49 μm and 199 μm 31.  The tumours with smaller vessel diameters had higher 
slope values than the tumours with larger vessel diameters 
31
.   
No significant difference was found between amplitudes of liver and kidney 
tissues in vivo.  Again, as in the cast study, we can thus neglect the affect that amplitude 
has on the spectral parameters and assume that the differences are due to physical 
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characteristics of the tissues. The midband fit and slope values of liver were 
significantly higher than those of kidney in vivo (no significant difference was found 
between intercept values).  The loss of significance in the intercept value when obtained 
in vivo may be due to a number of reasons.  The intercept value was shown to not be 
affected by small changes in the density of the absorbing structures (Figure 5.6).  The 
casted hepatic and renal vascular did show significant differences in their respective 
intercept values, however, this in combination with physiological differences (e.g. blood 
flow rate, blood pressure, and oxygenation of blood) which would not be present in the 
cast or simulated data may have caused the intercept values to shift.   
 Based on theoretical 
29,30
 and experimental results (microsphere phantoms), this 
study has shown, using three experimental medium (casts, simulation and in vivo), that 
the frequency response of OA signals can be used to describe unresolvable structures in 
an OA image.  Frequency analysis of OA signals from murine hepatic and renal vascular 
was used to discriminate between the two tissues based on the differences in their 
vascular characteristics 
1
.   These results suggest that this type of analysis of OA signals 
may be applied to distinguish between normal and neoplastic tissues as the latter tissues 
often have considerably different vascular characteristics compared with normal tissues 
23,32
.  Furthermore, knowledge of the vascular characteristics of neoplastic tissues is 
often highly beneficial in treatment planning 
2,3
.   
   This work demonstrates the ability of OA imaging to describe structural 
characteristics of targets through frequency analysis.  Structural differences between 
murine hepatic and renal vascular were detected using frequency analysis of vascular 
casts, computer simulation and in vivo methods.  Frequency results agreed with expected 
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results based on OA theory and controlled phantom study, in combination with the 
published characteristics of murine hepatic and renal vascular.  Due to the considerable 
difference in vascular characteristics between normal and cancerous tissues, these 
results suggest that cancerous tissues may be differentiated from normal tissues and 
characterized using this method. 
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CHAPTER 6 
SUMMARY AND FUTURE DIRECTIONS 
 
“What I am going to tell you about is what we teach our physics students in the third or 
fourth year of graduate school... It is my task to convince you not to turn away because 
you don't understand it. You see my physics students don't understand it... That is 
because I don't understand it. Nobody does.”  
-Richard P. Feynman (1918-1988) 
picture from http://www.goodreads.com/author/show/1429989.Richard_P_Feynman 
 
 
 
 
6.1 Summary 
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Prostate cancer is a common disease among men in developed countries and, 
fortunately, has a relatively high survival rate provided diagnosis occurs in its early 
stages 
1
.   However, methods of detection of the disease in its early stages remain 
unreliable due to the limitations of current diagnosis techniques 
2
.  Furthermore, 
treatments of early-stage prostate cancer, when diagnosed, are often associated with 
adverse side effects 
3
.    New treatment options for early-stage prostate cancer which 
have minimal to no side effects are available 
4
, but lack adequate monitoring tools.  
There is, thus, a growing need for techniques that are be capable of detecting prostate 
cancer with high contrast and high resolution, as well as modalities for monitoring these 
new, preferable prostate cancer treatments. 
OA imaging has been demonstrated to acquire high contrast and resolution 
images in real-time 
5
.  This thesis addresses one of the major limitations with OA 
imaging of prostate cancer; the need to use planar detection geometry in prostate 
imaging, which is often associated with relatively lower resolution when operating in 
real-time 
6–8
.  Frequency analysis of OA signals, described herein, may offer a means of 
providing sub-resolution detail to low resolution OA images.   This could greatly 
enhance the applicability of OA imaging in prostate cancer detection and monitoring by 
providing sub-resolution detail about the vasculature of the tumour (which is indicative 
of its aggressiveness), and physical changes that occur during treatment that indicate 
successful tumour destruction.  This analytical technique could strengthen all OA 
imaging applications, by providing complementary information to the current amplitude 
based analysis technique.   
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The experiments presented in this thesis aim to determine if optoacoustic signal 
intensity and frequency are sensitive indicators of physiological differences between 
healthy and neoplastic tissues, and to treatment-induced physiological changes.   
Before focusing on the cancer-related studies (i.e. cancer detection and therapy 
monitoring) the OA imaging system is characterized (Chapter 2).  The sensitivity, 
reproducibility, resolution and contrast (based on absorption coefficient) of the system 
was determined.  Knowledge of these parameters is essential for setting up the following 
experiments.  The sensitivity and reproducibility allow us to choose sample sizes (e.g. of 
in vivo animals, ex vivo tissue) that would yield results with high statistical power while 
limiting the number of animals sacrificed.   The resolution of the system was determined 
to be approximately 0.5 mm and the contrast of the system is capable of distinguishing 
targets with absorption coefficients that differed by more than 0.2 cm
-1
.  Therefore, 
when choosing an animal model for the in vivo studies the tissues to be detected must be 
at least 0.5 mm in diameter at the time of imaging and the absorption coefficients must 
differed from the surround tissues by more than 0.2 cm
-1
.  Thus, the absorption 
coefficients of TRAMP tumours compared to absorption coefficients of mouse prostate, 
and the absorption coefficients of mouse liver and kidney compared to the surrounding 
tissues differ by at least 0.2 cm
-1
. 
The SENO system has a relatively large pulse energy variation.  This may 
necessitate larger sample sizes and larger signal averaging to be performed to ensure our 
results are valid.  The annular array transducer is optimal for maximum intensity and 
integrated amplitude projection images.  The planar geometry detects large signals at 
boundaries which could be projected onto a two-dimensional plane to form the image.  
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The distance that a target is placed from the transducer, however, greatly impacts the 
amplitude of the detected signal (detected signal amplitude decreases up to 50% when 
the target is 5 mm away from the focal point of the transducer).  Therefore, targets could 
be imaged using this transducer at greater depths than those demonstrated in this thesis 
(>5 mm), if the laser energy is sufficient, and if the targets are positioned close to the 
transducers focus.  This degradation of detected signal also demonstrates that this 
system would not be optimal for three-dimensional imaging. 
The main research topics (i.e. prostate cancer detection and therapy monitoring) 
are presented in Chapters 3-5.  Chapter 3 describes the in vivo experiment which 
demonstrates the ability of OA imaging to detect tumours with high contrast and good 
resolution.  The major technical limitations of this study are the long image acquisition 
time (approximately 1.5 hours for each image) and that individual blood vessels are not 
well resolved.  A novel analytic technique (frequency spectrum analysis) is further 
developed and employed.  This technique shows promise in providing sub-resolution 
information that may be complementary to the information content in amplitude-based 
images.  Spectrum analysis involves removing system-dependent features by calibrating 
the spectrum with the frequency spectrum of the transducer.  Three frequency 
parameters (the slope, intercept and midband fit) are extracted from this calibrated 
spectrum.  The changes in these parameters could be quantitatively compared with 
parameters obtained using different OA systems (OA data cannot currently be 
quantitatively compared between systems). 
The greatest challenge of this study is the interpretation of the detected OA 
signals.  Significant differences in the amplitude of the OA signals are found on tumour 
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compared to surrounding tissues, however, this is not solely due to increased 
hemoglobin concentrations (and therefore absorption coefficients) as some of the 
tumours were visually not highly vascularized.  The changes in the signal may be due to 
the differences in the Grűneisen parameter between normal and neoplastic tissues 9.   
Significant differences in the frequency spectrums are also found.  This is interesting 
and important data as our understanding of the connection between the frequency of the 
OA signal and the specific target characteristics is limited.  This data leads to future 
studies (Chapter 5) to investigate the connection between the size and density of OA 
targets and the frequency spectrum of the resulting signals.  Using these results, the 
larger slope value on tumour compared with surrounding tissues indicates that the 
tumours are composed of blood vessels with smaller diameters, on average.  The higher 
intercept and midband fit values on tumour, in combination with the higher slope values, 
indicate that the tumours have a more dense network of blood vessels than the 
surrounding tissues.  These interpretations are consistent with the known characteristics 
of the TRAMP model in that the neoplastic prostate tissue consist of smaller and more 
dense blood vessels compared to normal prostate 
10–12
.  
Chapter 4 demonstrates the ability of OA imaging to monitor laser thermal 
therapy (LTT), by monitoring the change in OA signal strength (which is directly related 
to target temperature) during treatment, in real-time.  Post-heating (i.e. after the heating 
laser is turned off) as the tissue temperature decreased back to its initial temperature, the 
OA signal decreases slightly but remained higher than pre-treatment values.  This 
demonstrates that the amplitude of the OA signal is simultaneous affected by the 
temperature as well as the physical state of the tissue.   These two effects are difficult to 
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decouple and make OA monitoring of either temperature alone or tissue state alone very 
difficult.  Frequency spectrum analysis is performed on the data and the frequency 
parameters of the OA signals do not change when the heating laser is turned off and the 
tissue temperature decreases.  This indicates that the frequency of the OA signals may 
be related to the state of the tissue (e.g. native or damaged/coagulated) more so than to 
the temperature (which is used as a surrogate for damage).  This may offer a more direct 
method to detect and monitor tissue coagulation during thermal therapy compared to OA 
temperature prediction.   
 Chapter 5 further investigates the relationship between the target and the 
frequency spectrum of the OA signal.  A phantom experiment is performed to determine 
the relationship between the frequency parameters (the slope, midband fit and intercept) 
and the size and concentration/density of the targets.  The frequency parameters of two 
casted and in vivo tissues (mouse liver and kidneys) are measured and compared under 
the hypothesis that the frequency spectrum would be affected by the different vascular 
characteristics of the tissues (e.g. vessel diameters and densities).  Both casted and in 
vivo hepatic vasculatures have higher associated slope and midband fit values compared 
to those associated with renal vasculature.  These results, in combination with the results 
of the phantom study, are compared with published values of the density and sizes of the 
vessels of these two tissues (renal vasculature has larger vessels and lower vascular 
density on average compared to hepatic vasculature).   Based on the phantom study 
results, targets with larger vessel diameters and less vascular density would yield greater 
slope values and smaller midband fit and intercept values.  These experimental OA 
slope values for renal and hepatic vasculature are consistent with the known differences 
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in vascular size and density.   Characteristics associated with mouse hepatic and renal 
vasculature, obtained via CT imaging of the vascular casts and literature, are input into a 
computer script which simulates three-dimensional vascular trees of hepatic and renal 
vasculature and their associated OA signals.  Frequency analysis is then performed on 
these simulated signals and, as with the cast and in vivo data, the slope and midband fit 
values associated with hepatic vasculature are higher than those associated with renal 
vasculature. 
 This thesis addressed one of the major limitations of the use of OA for the 
imaging of prostate cancer.  Due to the location of the prostate gland, planar detection 
geometry must be employed in OA imaging which is associated with relatively low 
resolution when performed in real time.  The frequency-based analysis developed and 
tested in this thesis should contribute additional information on sub-resolution structures 
to OA images, which may provide for advanced detection and monitoring of prostate 
cancer.  Differences in vascular characteristics (between hepatic and renal vasculature) 
resulted in significant differences between the frequency parameters while the OA 
signal amplitude do not.  Neoplastic and the surrounding prostate tissues show 
significant differences in both the frequency and amplitude of the OA signal.   This 
analysis technique could be applied to any OA signal to provide additional information 
on sub-resolution tissue structures.  This would be especially important for low 
resolution systems.   Once the tumour is located, OA imaging can be used to monitor 
laser thermal therapy (LTT) in real-time.   The frequency spectrum of the OA signals 
may indicate tissue state (i.e. native and coagulated) rather than temperature based on 
the result in Chapter 4.  In combination with the amplitude of the OA signal, this may 
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provide the first treatment monitoring system for LTT which could provide temperature 
as well as tissue state information simultaneously.  This would be by far the most 
important finding of this thesis, from the clinical perspective. 
6.2 Future directions 
 There are many possibilities for further exploration arising from the work 
presented in this thesis, some of which have been noted in previous chapters.  Given the 
novelty of the frequency analysis technique and the limited published material exploring 
this technique, the potential for future study is understandably substantial.  While the 
focus of this thesis was on prostate cancer detection and treatment monitoring, it is 
reasonable to assume that other OA imaging applications would benefit from this 
technique.   
 Future studies directly stemming from this study could include further 
investigation into the relationship between the target characteristics (e.g. size, 
concentration, shape, etc) and the OA spectrum parameters.  Comprehensive studies 
must be performed to investigate this relationship, involving reliable phantoms with 
specific and varying physical characteristics (similar to the microsphere phantoms in 
Chapter 5).  Furthermore, the analysis technique used herein closely mimics that used in 
ultrasound image analysis.  Modifications to this technique may improve its validity.  
For example, the optimal method used to calibrate the RF tissue power spectrum (i.e. 
obtain the power spectrum of the transducer) is still unclear 
13,14
.    Vascular corrosion 
casts used for modeling complex vascular structures may be a valuable tool for 
investigating the relationship between the frequency response of the OA signal and a 
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complex vascular target.  Investigating vascular casts of tumours would be especially 
critical to advance the applicability of this technique.   
An in vivo study similar to the one performed in Chapter 3 with a larger number 
of animals may provide more accurate results.  A system with improved stability in laser 
pulse energy is desirable as it would reduce required signal averaging and likely 
improve the overall reproducibility.  In addition to tumour detection, laser thermal 
therapy (LTT) could also be performed in real-time and monitored using OA imaging in 
these models.  This is necessary to determine the affects of parameters such as blood 
flow on the OA signal amplitude and frequency spectrum during and post-heating.  The 
logical progression to advance this technique to a medically applicable state would then 
be to transition these studies into a more complex model (e.g. canine prostate) which 
would require the development of a transrectal OA system.   
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